Trading Analysis Report: NFLX

Generated: 2026-10-02 17:56:49

I. Analyst Team Reports

Market Analyst

Current Price: 67.85 Price As Of: 2026-10-01

NFLX (Netflix, Inc., NMS, Communication Services / Entertainment): Technical Report

Prices are in USD. All exact price and indicator values come from the verified snapshot, and the other tool outputs agree with it. Percentage distances to moving averages and bands are my own arithmetic on the verified values. The task date was 2026-10-01 and the latest bar available is that same day.

1. Indicators selected and why

I chose eight indicators that cover different jobs and don't duplicate each other:

Role	Indicator	Why it suits NFLX now
Trend (multi-timeframe)	supertrend	Gives direction and trailing-stop levels on weekly, monthly and daily bars.
Trend strength	adx	Tells us whether the decline is a real trend or just chop.
Momentum	rsi	Measures how oversold the stock is. I used it instead of StochRSI to avoid redundancy.
Momentum / trend change	macd (with signal and histogram)	Shows whether bearish momentum is still building or fading.
Volatility	boll_lb (with the middle and upper bands)	Marks where price sits against the lower band, a common oversold zone.
Volume	obv	Checks whether volume confirms or contradicts the price decline.
Exhaustion	td_9	Flags possible exhaustion on weekly, monthly and daily bars.
Mean-reversion stretch	z_score	Measures how far price is from its 20-period mean on each timeframe.

The snapshot also supplied the 10 EMA, 50 SMA, 200 SMA and ATR, which I use as context. I did not pull pdi or mdi, so I infer the ADX direction from price and SuperTrend.

2. Price action (127 sessions, 2026-04-01 to 2026-10-01)

• Peak and breakdown: The window's highest close was 107.79 on 2026-04-16. The next session, 2026-04-17, opened at 96.37 and closed at 97.31 on about 126M shares, a gap down on very heavy volume. That was the first of three such volume spikes in this window.
• Grinding lower: The stock slid from the mid-90s in late April to a close of 70.90 on 2026-06-25. There was a second heavy-volume leg down on 2026-06-22, when it closed at 72.88 on about 82M shares.
• Second gap down: On 2026-07-17 the stock opened at 65.48 and closed at 68.95 on about 142M shares, the heaviest volume in the window. The intraday low that day was 65.08. The lowest close in the window before today was 67.60 on 2026-07-20.
• Recovery: From 67.60 on 2026-07-20, the stock rose to 82.73 on 2026-09-02 and 82.67 on 2026-09-03. That was a rebound of roughly 22%, but it stayed well below the April high.
• Renewed selling: The stock dropped from 82.67 to 78.25 on 2026-09-04, then 80.32 on 2026-09-14 was a lower bounce high. On 2026-09-18 it gapped down from 75.31 to an open of 71.27 and closed at 71.79 on about 114M shares. The tools don't say why. It has since made lower closes on most sessions.
• Today: The 2026-10-01 bar opened at 69.41, ranged 67.79 to 69.66, and closed at 67.85 on about 41.6M shares. That is a lower close for the third straight day (70.30 → 69.58 → 67.85). The close is just above the 2026-07-20 closing low of 67.60.

The prior two heavy-volume gaps (2026-04-17 and 2026-07-17) came in mid-April and mid-July. A mid-October event is therefore plausible, but nothing in the tool output confirms an earnings date. Treat gap risk as a live consideration and check the calendar separately.

3. Trend: fully bearish across timeframes

Moving-average stack (verified): - 10 EMA is 71.09, 50 SMA is 75.60 and 200 SMA is 84.20. - Price (67.85) is below all three, and the averages are in descending order, which is a textbook bearish structure. - Price is about 4.6% below the 10 EMA, 10.3% below the 50 SMA and 19.4% below the 200 SMA.

SuperTrend (14, 3x ATR): - Weekly (the highest-weighted tier) is DOWN, with a trailing stop at 86.41. Price is 21.48% below it. - Monthly is DOWN, with a stop at 106.13. Price is 36.07% below it. - Daily is DOWN, with a stop at 74.86. Price is 9.36% below it. - All three tiers agree, so there is no timeframe conflict. The weekly and monthly stops are far away, so a trend flip there is not a near-term event. The daily line at 74.86 is the nearest reference for a short-term trend change.

ADX is 34.93 and rising fast: - It was 9.07 on 2026-09-17, 15.42 on 2026-09-18, 23.10 on 2026-09-25 and 26.45 on 2026-09-28. It then went 28.85, 31.31 and 34.93. - Early September was range-bound, with ADX in the teens. The late-September decline has turned it into a confirmed, strengthening trend (above 25). - Combined with price below the SuperTrend lines, this is a strong downtrend. Trend-following signals are more reliable here than in the earlier chop, and counter-trend trades are riskier.

4. Momentum: bearish, but nearing oversold

• RSI is 32.45. It is close to the 30 oversold threshold but has not crossed it. In a strong trend (ADX near 35), RSI can stay depressed or fall below 30 before a bounce, so RSI alone is not a buy signal.
• MACD is -2.31, the signal line is -1.57 and the histogram is -0.74. The MACD line is below the signal line and below zero. A negative histogram means downside momentum is still ahead of its smoothed average. There is no bullish crossover and no sign of the histogram turning up.

5. Volatility and stretch

• Bollinger Bands: The middle band is 74.28, the upper is 82.29 and the lower is 66.27. Price is about 2.4% above the lower band (1.58 points). Today's low of 67.79 did not touch it. A close below 66.27 would be a lower-band breach, which in a strong trend often means the price is "walking the band" rather than reversing.
• ATR is 2.04, about 3% of price. That is a useful unit for sizing stops. One ATR below the close is about 65.81, which is just under the lower band and near the 2026-07-17 intraday low of 65.08.
• Z-score (20-period): Daily is -1.61, weekly is -1.54 and monthly is -1.49. All three tiers are below the mean and none has reached the |2| threshold. The stock is stretched but not statistically extreme, so a bounce would not be unusual but the signal is not strong. All tiers also agree, with no conflict to resolve.

6. Volume confirmation

• OBV fell from 405.65M on 2026-09-02 to 9.93M on 2026-10-01, the lowest reading in the displayed window.
• It dropped sharply on the heavy-volume days: from 236.37M on 2026-09-17 to 121.96M on 2026-09-18, and from 87.93M on 2026-09-29 to 51.52M on 2026-09-30.
• Today's drop from 51.52M to 9.93M matches today's 41.58M volume, so the data is internally consistent.
• Price and OBV are both making new lows, so there is no bullish divergence. Selling is being confirmed by volume. I did not pull MFI, so I have no second volume reading.

7. Exhaustion signals: mixed timeframes

• Daily TD-9 is +9, a completed buy setup and therefore a reversal watch. It means about nine consecutive sessions of the sequence condition, which hints the short-term sell-off is mature.
• Weekly is +4 and monthly is +5. The higher-weighted tiers are only part-way through their setups. The tool guidance says a daily 9 does not override a weekly setup still in progress.
• So the most credible reading is that a short-term bounce is possible, but the larger downtrend has room to extend. The daily 9 is an early warning to watch, not confirmation of a bottom.

8. Key levels (from observed data)

Support (downside): - 67.60 is the 2026-07-20 close, the lowest close in the window. Today's close is only 0.25 above it. - 66.27 is the lower Bollinger Band. - 65.08 is the 2026-07-17 intraday low and the lowest low in the window.

Resistance (upside): - 69.58 and 70.30 are the last two closes, and 71.09 is the 10 EMA. A close back above the 10 EMA would be the first sign of short-term stabilization. - 72.38 to 75.31 is the area of the 2026-09-18 gap down. The 2026-09-21 high of 73.87 sits inside it. - 74.28 is the Bollinger middle band and 74.86 is the daily SuperTrend. A close above these would be the first real evidence of a daily trend change. - 75.60 is the 50 SMA. - 80.32 is the 2026-09-14 bounce high, and 82.29 is the upper Bollinger Band.

I am treating these as reference levels only. The tools don't give enough history to claim they have held or failed repeatedly, beyond the single rebound from the July low noted above.

9. Scenarios

Bearish continuation (higher probability given trend evidence): - Evidence: all three SuperTrend tiers are down, ADX is 34.9 and rising, the MACD histogram is negative, OBV is confirming, and the weekly and monthly TD counts are still early. - A close below 67.60 would put the July low region at 65 to 66 in play, together with the lower band at 66.27. - A heavy-volume gap, as on 2026-04-17, 2026-07-17 and 2026-09-18, could skip these levels.

Relief bounce (plausible but lower conviction): - Evidence: a completed daily TD-9, RSI at 32.45, daily and weekly z-scores near -1.6 and -1.5, and price near the lower band and the July closing low. - Confirmation would be a close above the 10 EMA (71.09), and then a recovery toward the gap area at 72 to 75. - Even a successful bounce would run into the daily SuperTrend (74.86) and the 50 SMA (75.60) while the weekly trend is still down.

10. Summary for the decision-maker

NFLX is in a confirmed, strengthening downtrend at its lowest close since 2026-07-20, with all three SuperTrend tiers pointing down and volume confirming the sell-off. The only counter-signals are short-term: a completed daily TD-9, RSI close to oversold, and moderate negative z-scores. None of them is extreme, and there is no OBV or MACD divergence yet.

Tactically, the stock sits between the 67.60 closing low and the 66.27 lower band below, and the 71.09 10 EMA above. Position size should reflect the roughly 2.04 ATR and the risk of overnight gaps. My tools don't establish an earnings date, so that risk needs a separate check.

Key points table

Item	Reading (verified)	Interpretation
Close (2026-10-01)	67.85	Third straight lower close, just above the 67.60 closing low of 2026-07-20
10 EMA / 50 SMA / 200 SMA	71.09 / 75.60 / 84.20	Price is below all three, in a bearish stack
SuperTrend weekly (Tier 1)	DOWN, stop 86.41 (-21.48%)	Primary trend is down
SuperTrend monthly (Tier 2)	DOWN, stop 106.13 (-36.07%)	Long-term regime is down
SuperTrend daily (Tier 3)	DOWN, stop 74.86 (-9.36%)	Nearest trend-flip reference
ADX	34.93, up from 9.07 on 2026-09-17	Strong and strengthening trend, now tradable
RSI	32.45	Near oversold but not below 30, which is not a standalone buy signal
MACD / signal / histogram	-2.31 / -1.57 / -0.74	Bearish momentum, no turn yet
Bollinger lower / middle / upper	66.27 / 74.28 / 82.29	Price is about 2.4% above the lower band
ATR	2.04 (about 3% of price)	Use for stops and sizing
OBV	9.93M, down from 405.65M on 2026-09-02	Volume confirms the decline, with no divergence
TD-9 (daily / weekly / monthly)	+9 / +4 / +5	Daily exhaustion watch, but higher tiers are still early
Z-score (daily / weekly / monthly)	-1.61 / -1.54 / -1.49	Stretched below the mean but short of the
Support levels	67.60, 66.27, 65.08	Closing low, lower band, July intraday low
Resistance levels	71.09, 72.38 to 75.31, 74.86, 75.60	10 EMA, September gap area, daily SuperTrend, 50 SMA
Gap-risk pattern	Heavy-volume gaps on 2026-04-17, 2026-07-17, 2026-09-18	Event risk is high, and an earnings date is not confirmed by the tools
Overall bias	Bearish trend, with a possible short-term relief bounce	Wait for a reclaim of 71.09 and then 74.86 before treating the trend as changing

Sentiment Analyst

Overall Sentiment: Neutral (Score: 5.0/10) Confidence: Low

NFLX sentiment report, 2026-09-24 to 2026-10-01: no usable sentiment data

Bottom line: None of the three sources returned any content for this window. The Neutral band and 5.0 score are placeholders. They mean there is no evidence, not that sentiment is balanced. Please don't read them as a real signal in either direction.

1. Source-by-source breakdown - Yahoo Finance news: Unavailable. The placeholder says the feed only serves recent items, so this is a retrieval limitation. It does not mean there was no NFLX news. I have 0 headlines and can't characterize institutional framing. - StockTwits: Unavailable, for the same reason. I have 0 messages, so there is no Bullish/Bearish ratio, no sample size, and no read on retail positioning for $NFLX. - Reddit (r/wallstreetbets, r/stocks, r/investing): Skipped because the sentiment_include_reddit config is disabled. I have 0 posts. This is a configuration choice, not a data failure, and the result is the same: nothing to analyze.

2. Cross-source divergences and alignments I can't assess these. With no source returning data, I can't compare news framing against retail sentiment.

3. Dominant narrative themes None can be identified. I won't infer themes such as subscriber growth, ad-tier momentum, pricing, content slate, or competition from my background knowledge, because none of that is in the supplied evidence.

4. Catalysts and risks The data surfaced none. I don't have the following, and I'm not asserting anything about them: - The date of the next earnings report. Netflix has typically reported in mid-October, but I can't confirm that from the supplied evidence. - Any company-specific news from the window. - Macro or sector developments.

The trader should check these through other channels.

5. Data-quality caveats - All three sources are empty, so confidence is low. - The sentiment read is effectively uninformative. The trader should rely on fundamentals, technicals, and independently sourced news, and should not use this report to tilt the decision either way. - Re-running the collection with a source that covers this window, or enabling Reddit, would be needed to produce a real read.

Summary table

Signal	Direction	Source	Supporting evidence
Institutional news framing	Unknown	Yahoo Finance	Feed unavailable for the window; 0 headlines
Retail Bullish/Bearish ratio	Unknown	StockTwits	Feed unavailable; 0 messages
Community discussion	Unknown	Reddit	Disabled by config; 0 posts
Cross-source divergence	Not assessable	All	No data from any source
Overall	Neutral (placeholder, no evidence)	All	Score of 5.0 reflects the absence of data, not balanced sentiment

News Analyst

NFLX News and Macro Report (week ending 2026-10-01)

Data coverage

Most of my sources returned nothing usable, so this report is thin. I have not filled the gaps with guesses.

Source	Result
NFLX company news (09-24 to 10-01, and 09-01 to 10-01)	Unavailable. The vendor serves only recent items, and it said this does not mean there was no news.
FRED macro data (fed funds, 10-year Treasury, CPI, unemployment, VIX)	Unavailable. FRED_API_KEY is not set. I have no readings for rates, inflation, labor or volatility.
Prediction markets (Fed cuts, recession)	Withheld for 2026-10-01. Polymarket only serves live odds, so serving them would leak later information into this date.
Global news	Returned headlines only, with no article text. Most are mining and small-cap items and none mention NFLX.

What the headlines show

These come from headline titles only. I could not read the articles, so the details are unverified.

1. Inflation data: A Yahoo Finance silver-price piece dated Oct 1 says prices "gain some ground following the latest PCE report." A PCE release landed around Sept 30 to Oct 1. I can't see the figures or whether they beat or missed expectations. The release matters for rate expectations, which affect long-duration growth stocks like NFLX.
2. Market-breadth warning: MarketWatch ran "The stock market is a hollow tree that could be about to snap, warns bond king Gundlach." This is a bearish view from one prominent investor about narrow leadership and fragile valuations. It is sentiment, not data.
3. Tech and IT services:
4. IT services stocks rallied (EPAM, DXC, EXL, Grid Dynamics, Concentrix, TaskUs). The rally appears tied to Accenture's earnings.
5. IBM rose on the Accenture results.
6. Barron's listed Micron, Accenture, Google, IBM, Fair Isaac and Synopsys among the stocks driving the market.
7. Together these suggest decent risk appetite in tech and AI-related areas. Google appears in the list, but I can't tell why.
8. Commodities: Coverage is dominated by precious metals and mining (silver, gold, copper, critical minerals) and a "September's top commodity performers" roundup. This shows strong interest in metals, but I have no price levels, so I can't say what it means for the macro backdrop.

Implications for NFLX

• I found no NFLX-specific catalysts, such as earnings dates, pricing changes, content or ad-tier news, or analyst actions.
• Netflix's Q3 earnings normally come in mid-October. That is general knowledge and not confirmed by my tools. If the date holds, the next two weeks could bring pre-earnings positioning and elevated volatility. Another agent should confirm the date.
• Rate expectations and the PCE reaction are the main macro channels I can identify for NFLX. I have no figures for either.
• Gundlach's warning, together with a market led by a narrow group of stocks, is a downside risk for high-multiple names. The tech rally in the same headlines points the other way.

Gaps for the next analyst

• NFLX price action, earnings date and estimates, and recent analyst notes.
• The actual PCE and core PCE figures, the fed funds rate, the 10-year yield and curve, the unemployment rate and the VIX.
• Market-implied odds for Fed policy and recession.

Summary table

Area	Finding	Source quality	Relevance to NFLX
NFLX company news	None retrievable	Tool unavailable	Unknown; no catalysts confirmed
Inflation (PCE)	New PCE report released around 09-30 to 10-01; figures not seen	Headline only	Affects rate expectations and growth multiples
Fed funds, 10-year yield, CPI, unemployment, VIX	No data	FRED key missing	Cannot assess
Prediction markets	Withheld for this date	Policy restriction	Cannot assess
Market sentiment	Gundlach warns of a fragile, narrow market	MarketWatch headline	Downside tail risk for high-multiple stocks
Tech and IT services	Rally tied to Accenture earnings, with IBM and Micron also in focus	Headlines only	Mildly supportive of risk appetite
Commodities	Heavy precious-metals and mining coverage	Headlines only	Little direct link
Upcoming events	Q3 earnings likely mid-October (unconfirmed)	General knowledge	Possible volatility catalyst

Bottom line: My tools do not support a directional view on NFLX. The only signals are the Gundlach warning on market fragility and the Sept 30 to Oct 1 PCE release, and I could not verify either beyond the headlines.

Fundamentals Analyst

NFLX (Netflix, Inc.) Fundamental Report, as of 2026-10-01

0. Data scope and caveats

• Profile data is unavailable. get_fundamentals withheld market cap, valuation multiples, the 52-week range and the company profile for this date. The vendor serves only present-day values, which would leak post-decision information. All valuation comments below are therefore approximate. I built them from reported financials and from prices in the insider-transaction records.
• The latest reported quarter is Q2 2026 (ended 2026-06-30). Q3 2026 ended yesterday and has not been reported. Past years' timing suggests results in mid-October, but no tool confirms the date. The Q3 print is the nearest catalyst.
• A stock split is visible in the data. Insider sale prices fall from about $1,100 (Nov 2025) to about $107 (Dec 2025). Share counts are now about 4.2B. This is consistent with a 10-for-1 split in Nov 2025. Prices below are split-adjusted unless noted.
• The tools give no subscriber data, guidance or segment/geography detail. I couldn't verify the cause of one-off items. Where I infer a cause, I say so.

1. Income statement trends (quarterly, $B except EPS)

Quarter	Revenue	Gross profit	Gross margin	Operating income	Op. margin	Net income	Diluted EPS
Q2'25	11.08	5.75	51.9%	3.77	34.1%	3.13	0.719
Q3'25	11.51	5.35	46.4%	3.25	28.2%	2.55	0.587
Q4'25	12.05	5.53	45.9%	2.96	24.5%	2.42	0.560
Q1'26	12.25	6.36	51.9%	3.96	32.3%	5.28	1.23
Q2'26	12.56	6.52	51.9%	4.19	33.4%	3.40	0.80

Q2 2026 versus the prior year and prior quarter - Revenue grew +13.4% year over year and +2.5% quarter over quarter. - Operating income grew +11.1% year over year. Operating margin was 33.4%, about 70 bps below Q2'25's 34.1%, so margins compressed slightly while revenue grew double digits. - Gross margin was flat at 51.9%. Cost of revenue grew about 13.4% (6.04B vs 5.33B), in line with revenue. - Net income grew +8.8% and diluted EPS +11.3% (0.80 vs 0.719). EPS grew faster than net income because diluted shares fell about 2.0% (4.261B vs 4.349B). - Operating expenses were $2.33B, up 17.7% year over year. R&D (technology) grew 22% to $1.01B and is now the fastest-growing cost line. Sales and marketing grew 15.5% to $0.82B. G&A grew 13% to $0.50B. - The Q2 tax rate was about 16.4% (0.667B on 4.07B pretax income). Q1 was about 19.3%.

Reading the weak Q3'25 and Q4'25 margins. Operating margin dropped to 28.2% in Q3'25 and 24.5% in Q4'25, then recovered to 32–33% in 2026. Q4'25 had unusually high cost of revenue (6.52B) and S&M (1.11B). Margins have now rebounded to near prior-year levels. The tools don't say what caused the dip, so I won't attribute it.

Q1 2026 non-operating item. - Q1'26 "interest income" was $2.85B, against roughly $0.04–0.05B in the other quarters. Net interest income was +$2.59B. That is why net income of $5.28B and EPS of $1.23 are not representative. - Q1 operating income of $3.96B is unaffected. - The same quarter shows a $586M business acquisition in investing cash flow. - Netflix has no interest-income base that could produce $2.85B, so this is almost certainly a one-time gain. The tool doesn't identify it. The size is consistent with a deal termination or break-up payment, but I can't verify that. - Treat the TTM net income of about $13.65B and TTM EPS of about $3.18 as inflated by this item.

TTM (last four reported quarters, Q3'25–Q2'26) - Revenue was about $48.4B. - Operating income was about $14.4B, a margin of about 29.8%. This includes the weak Q3'25 and Q4'25 quarters. - Net income was about $13.65B and diluted EPS about $3.18, both flattered by the Q1 item. - Stripping out roughly $2.8B of pre-tax one-time income (a rough estimate), normalized TTM EPS would be about $2.5–2.6. - The latest insider-sale prices (Sept 2026) were about $75–78. At roughly $76, that implies about 24x reported TTM EPS and about 29–30x normalized. The share price on 10/1 is not in my data, so check it against live quotes.

2. Balance sheet (as of 2026-06-30)

Item	Q2'26	Q1'26	Q4'25	Q2'25
Cash & equivalents	$9.10B	$12.26B	$9.03B	$8.18B
Total debt	$14.31B	$14.36B	$14.46B	$14.45B
Net debt	$5.21B	$2.10B	$5.43B	$6.28B
Current debt (due within 1 year)	$2.48B	$1.00B	$1.00B	–
Long-term debt	$11.83B	$13.36B	$13.46B	$14.45B
Total assets	$58.45B	$61.02B	$55.60B	$53.10B
Total liabilities	$28.30B	$29.89B	$28.98B	$28.15B
Shareholders' equity	$30.15B	$31.13B	$26.62B	$24.95B
Working capital	$1.72B	$4.94B	$2.04B	$3.05B
Content/intangible assets	$33.84B	$33.38B	$32.78B	$32.09B

• Leverage is modest. Net debt is $5.2B against TTM operating income of about $14.4B. EBIT covers interest expense about 24x ($4.24B vs $0.176B in Q2). Debt is flat at about $14.3–14.5B, and no new debt was issued in the periods shown.
• A debt maturity wall is building. Current debt rose to $2.48B from $1.0B, because more long-term debt moved into the one-year bucket. The company can repay it from cash, or refinance it.
• Liquidity tightened from the Q1 peak. Cash fell $3.16B in Q2 to $9.1B, and working capital fell from $4.94B to $1.72B. The main drivers were record buybacks and a $1.25B drop in accrued expenses. Current liabilities of $12.1B are still covered by current assets of $13.9B (current ratio about 1.14).
• Receivables. These were flat at $2.0B in Q2, up from $1.69B in Q3'25.
• Net PP&E is rising, to $2.40B from $1.74B a year ago (+38%), and construction in progress is up. This suggests investment in physical production or infrastructure. Capex is still small (about $0.2B per quarter).
• Equity. The Q2 equity decline is explained by treasury stock rising to $28.4B from $23.7B. Tangible book value is negative (–$3.7B), which is normal because content assets are counted as intangibles.

3. Cash flow

($B)	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26
Operating cash flow	2.42	2.83	2.11	5.29	1.74
Capex	–0.16	–0.16	–0.24	–0.20	–0.22
Free cash flow	2.27	2.66	1.87	5.09	1.53
Share repurchases	–1.65	–1.86	–2.08	–1.27	–4.71
Content amortization	3.83	4.00	4.76	4.22	4.31
Content/other non-cash adjustment*	–3.93	–4.49	–4.87	–4.60	–4.97

*My reading is that the "Other Non Cash Items" line is mostly cash spent on content additions. I infer that and can't confirm it.

• Q2'26 FCF fell 33% year over year ($1.53B vs $2.27B), despite net income growing 9%. Two reasons:
• Working capital drained $1.3B, mostly from accrued expenses.
• Cash content spend was about $4.97B against $4.31B of amortization, a ratio of about 1.15x. A year earlier it was about 1.03x. If this ratio keeps rising, FCF conversion weakens even when GAAP earnings are solid.
• TTM FCF was about $11.15B. That is a margin of about 23% on TTM revenue, but about $2.8B of it is probably related to the one-time Q1 item. Normalized FCF is therefore closer to $8.3B, or about 17% of revenue.
• Buybacks.
• Q2 repurchases were $4.71B, more than 3x the Q1 level and 3.1x Q2'25. That is about 3x Q2 FCF. First-half 2026 buybacks were about $5.99B against about $6.62B of FCF.
• Over TTM, repurchases were about $9.9B against FCF of about $11.2B.
• The Q2 buyback was funded partly from the cash built up in Q1.
• Stock-based compensation was $131M in Q2, up from $81M a year ago (+62%) but still only about 1% of revenue.
• Share count. Ordinary shares outstanding fell to 4.164B from 4.237B at Q3'25 (–1.7%).

4. Insider transactions (last 150 records, May 2025–Sept 2026)

Pattern. The records show heavy selling and no open-market purchases at all. Most of the sales are option exercises followed by same-day sales. That is typical of a scheduled plan, and the tool doesn't say which sales were on plans.

Last 90 days (July–Sept 2026)

Date	Insider	Role	Action	Value
8/4	Sarandos	Co-CEO	Sold 133,162 sh @ ~$73	$9.73M
8/6	Peters	Co-CEO	Sold 27,312 sh @ $73.54	$2.01M
8/10	Neumann	CFO	Sold 9,248 sh @ $75.79	$0.70M
8/4	Hyman	Officer	Sold 5,723 sh @ $72.85	$0.42M
8/5, 9/8, 9/10	Barton	Director	Option exercises and sales @ ~$75–78	~$0.33M total

• Sales in the last 90 days were about $13.2M. This is much lower than the Hastings-driven selling earlier in the year.
• Reed Hastings (co-founder, now a director) sold about $33–45M every month from Dec 2025 through June 2026. Examples: $33.2M on 6/1/26, $38.0M on 5/1/26 and $40.2M on 4/1/26. The latest Hastings sale in this data is 6/1/26, and he shows no sales in July–Sept. He also made stock gifts (Nov 2025, Feb 2026).
• Bradford Smith (director) sold $2.8M in June 2026.
• Neumann (CFO) has sold in many months, including $5.5M in Feb 2026.
• Entries with no price or value (e.g., 8/3/26 and 5/4/26 for several executives) look like share withholding for taxes on vesting. They are probably not discretionary sales.
• Large stock awards were granted on 1/7/26, e.g. 207,420 shares each to the two co-CEOs.

Price path implied by insider-sale prices (split-adjusted). The stock was about $133 at the mid-2025 peak. It was about $107 in Dec 2025, $83–98 in Q1 2026, and $98 on 4/2/26. It then fell to $88 in May, $86 in early June and $73–78 from mid-June to Sept. That is roughly 40–45% below the mid-2025 peak. I'm deriving this from the sale prices, not a price tool.

5. Key takeaways for traders

Positives 1. Double-digit revenue growth (+13%) with stable gross margin and an operating margin around 33%. 2. EPS grows faster than net income because of an aggressive buyback. The share count is down about 2% year over year. 3. Balance sheet risk is low: net debt is about 0.4x operating income and interest coverage is about 24x. 4. Insider selling has slowed a lot since June. The most recent sales are small, and Hastings's regular sales have not appeared since June.

Risks and watch items 1. FCF is weakening in the core business. Q2 FCF was down 33% year over year, and cash content spend is running above amortization. 2. Headline earnings are distorted. The Q1'26 gain of about $2.8B (nature unverified) inflates TTM EPS and FCF. Use normalized figures when valuing the stock. 3. Capital allocation. The Q2 buyback of $4.71B was about 3x FCF. If the Q3 buyback stays at that level, cash would fall below the $9.1B reported at Q2, unless the Q3 operating cash flow is strong. 4. Debt. The $2.5B current debt maturity needs repayment or refinancing. 5. Cost growth. Operating expenses are growing faster than revenue (+17.7% vs +13.4%), led by R&D (+22%). This is the main threat to operating margin. 6. Sentiment. The stock has fallen about 40% over the past year while the business kept growing and insiders kept selling. Check whether this reflects multiple compression or a specific issue that isn't in the financial statements, such as deal-related news.

What to look for in the Q3 2026 report (likely mid-October) - Revenue growth of 12–14%. - Operating margin versus Q3'25's depressed 28.2%, which gives an easy comparison. - FCF versus the Q3'25 figure of $2.66B. - The pace of buybacks versus the Q2 figure of $4.7B. - The ratio of content cash spend to amortization.

6. Summary table

Category	Metric	Latest value	Trend / comment
Revenue	Q2'26	$12.56B	+13.4% YoY, +2.5% QoQ
Revenue	TTM	~$48.4B	Steady growth
Profitability	Gross margin	51.9%	Flat YoY
Profitability	Operating margin	33.4%	Down ~70 bps YoY, recovering from Q4'25 low of 24.5%
Profitability	Net income	$3.40B	+8.8% YoY
Profitability	Diluted EPS	$0.80	+11.3% YoY
One-time item	Q1'26 interest/other income	$2.85B	Inflates Q1 EPS ($1.23) and TTM; cause unverified
Costs	Operating expenses	$2.33B	+17.7% YoY; R&D +22%
Cash flow	Q2'26 FCF	$1.53B	–33% YoY
Cash flow	TTM FCF	~$11.2B	~$8.3B excluding the probable one-time amount
Content	Cash spend / amortization	~1.15x	Up from ~1.03x a year ago
Buybacks	Q2'26	$4.71B	~3x Q2 FCF; 1H26 about $6.0B
Shares	Shares outstanding	4.164B	–1.7% vs Q3'25
Balance sheet	Cash	$9.10B	Down $3.16B QoQ
Balance sheet	Total debt / net debt	$14.3B / $5.2B	Low leverage; interest coverage ~24x
Balance sheet	Current debt	$2.48B	Up from $1.0B; refinancing or repayment needed
Balance sheet	Equity	$30.2B	Reduced by buybacks
Insiders	Last 90 days	~$13.2M sold, 0 bought	Mostly executive sales plus small director sales
Insiders	Reed Hastings	Monthly sales Dec'25–Jun'26 ($33–45M each)	None shown July–Sept
Price context	Recent price	~$73–78 (Aug–Sept insider sale prices)	~40–45% below the 2025 peak
Valuation	Trailing P/E	~24x reported, ~29–30x normalized (est. at ~$76)	Approximate, since the tool withheld valuation data
Upcoming	Q3'26 earnings	Likely mid-October (unconfirmed)	Key catalyst

II. Research Team Decision

Bull Researcher

Bull Analyst: # The Bull Case for NFLX: Half Off the Peak While the Business Keeps Growing

I'll open with the thesis, then take on the objections I expect from the bear.

Thesis: this is multiple compression, not business deterioration

At $67.85, NFLX is about 37% below its April 16 close of $107.79 and roughly 49% below the mid-2025 peak of about $133. Over that stretch the business got bigger and more profitable:

• Revenue: Q2'26 was $12.56B, up 13.4% year over year.
• Operating income: $4.19B, up 11.1%. Gross margin was flat at 51.9% and operating margin was 33.4%.
• EPS: $0.80, up 11.3%, helped by a share count that is down about 2% year over year.

The stock has roughly halved while earnings grew double digits. That is the opportunity.

Valuation at today's price

The fundamentals report priced the stock at about $76. It is now about 11% cheaper.

Metric	At $67.85
Market cap (4.164B shares)	~$282B
EV (net debt $5.2B)	~$288B
EV / TTM operating income ($14.4B)	~20x
P/E on reported TTM EPS ($3.18)	~21x
P/E on normalized TTM EPS ($2.5–2.6)	~26–27x
P/E on Q2 run-rate EPS ($0.80 × 4)	~21–22x
TTM buybacks / market cap ($9.9B)	~3.5%

I'm using the normalized figures because the Q1'26 $2.85B non-operating gain inflates reported numbers. I'm not leaning on that item. About 20x EBIT for a 13% grower with 52% gross margins and a shrinking share count is not demanding.

The near-term catalyst has an easy comparison

Q3 results likely come in mid-October, though no tool confirms the date. Q3'25 operating margin was a depressed 28.2%, with operating income of $3.25B. This is my arithmetic, not guidance. If revenue grows 12–13% and margin returns to 32–33%, operating income lands around $4.1–4.3B, up roughly 25–30% year over year. If EPS holds near Q2's $0.80, that is up about 36% against Q3'25's $0.587. A clean comparison like that can change how the market frames the story.

Technicals: bearish trend, but the setup favors buyers

I won't pretend the trend is up. All three SuperTrend tiers are down and ADX is 34.9. But the risk/reward at this level is lopsided:

• Downside is tight. Price is 0.25 above the July 20 closing low of $67.60. The lower Bollinger Band is at $66.27 and the July 17 intraday low is $65.08. A move to $65.08 is about -4%.
• Upside is wide. The daily SuperTrend is at $74.86 (+10%) and the 200 SMA is at $84.20 (+24%). That is about 6:1 on the extremes.
• Short-term exhaustion signals are lining up. Daily TD-9 is complete, RSI is 32.45, and the daily z-score is -1.61.
• The July low was bought. On July 17, the heaviest-volume day in the window, the stock opened at $65.48 and closed at $68.95. It then rallied about 22% to $82.73 by September 2.

Pre-empting the bear

"FCF fell 33% in Q2." That is one quarter, and a $1.3B working-capital drain (mostly accrued expenses) explains much of it. TTM FCF is $11.15B, or about $8.3B with my rough adjustment for the one-time item. That is still a 3–4% yield on today's market cap. Cash content spend at 1.15x amortization is investment behind 13% revenue growth, not distress. I'll concede it is the number to watch in Q3.

"Buybacks were 3x FCF." Q2 was funded from cash built in Q1. For the first half, buybacks of $5.99B were below FCF of $6.62B. The company also bought more stock at lower prices, which is more accretive. Leverage is low: net debt is about 0.36x TTM EBIT and interest coverage is about 24x.

"Opex is growing faster than revenue." It is, at +17.7% versus +13.4%, led by R&D at +22%. But gross margin is flat and operating margin is only about 70 bps below last year, so the cost growth has not hurt profitability. It is a watch item, not a thesis-breaker.

"Insiders are sellers." They are, but the last 90 days total about $13.2M, which is negligible against a roughly $282B market cap. Most of it is option exercises and sales. Hastings has not sold since June 1, after monthly sales of $33–45M. The co-CEOs received large grants in January. I'll admit there are no open-market buys.

"The market is a hollow tree" (Gundlach). That is one headline. NFLX has already derated by roughly half, so it is not the crowded leader that a narrow-market unwind would hit hardest.

What I don't know

• The cause of the 9/18 gap down is unexplained in my data. The fundamentals through Q2 show no deterioration, so if the bear has a specific cause, I want to hear it.
• Sentiment, news and macro data came back empty, so I'm not citing any.
• The earnings date is unconfirmed.

What would change my mind

• A close below $65 on volume, which would break the July low.
• Q3 FCF down again with buybacks still outrunning it.
• Operating margin failing to recover from Q3'25's 28.2% comparison.

The stock is priced as if the business has a problem, and the reported numbers don't show one. Bear, what's your explanation for the gap between price and fundamentals? Bull Analyst: # Bull Rebuttal: Take the Cash Test, Because the Stock Is Priced for It to Fail

You made several good points, so I'll start by conceding them.

What I concede

• The risk/reward ratio. My 6:1 compared the nearest support to the farthest resistance. Like for like it is -4.1% to +10.3%, about 2.5:1. That is still positive, but it isn't the lopsided setup I described.
• The tax rate. At Q1's 19.3% rate, Q2 EPS would be about $0.77. That is $3.08 annualized, or about 22x. My "21-22x run-rate" survives that adjustment, but the rate did help.
• A price stop isn't protection here. Three gap days in this window were 5-10%. A gap through $65 fills below $65.
• 20x EBIT is not the whole valuation. EBIT is pre-tax and ignores content cash spend. Your cash lens is the right one for this company.

1. The cash multiple is a range, and Q3 settles it

Your 34x EV/FCF assumes Q2's $1.3B working-capital drain repeats. If it doesn't, Q2 FCF would have been about $2.83B, or $11.3B annualized. That is about 25x EV/FCF and a 4.0% yield. So the cash case runs from roughly 25x to 34x, depending on one line item that the fundamentals report calls mostly accrued expenses. That is my arithmetic, and I can't see what drove the accruals.

This also changes your Q3 hurdle. You say Q3 needs +74% sequentially, "requiring the whole $1.3B drain to reverse." It doesn't. It only needs the drain not to repeat. Q2 ex-drain is $2.83B against the $2.66B bar.

On content spend, your trend claim doesn't hold up. Using the fundamentals report's inferred cash-spend line:

	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26
Cash spend / amortization	1.03x	1.12x	1.02x	1.09x	1.15x

The ratio is lumpy, not rising steadily. Q3'25, the quarter we are comparing against, ran at 1.12x and still produced $2.66B of FCF. TTM comes to about 1.09x. Q2 at 1.15x is the high, not a trend.

2. Buybacks: the sunk cost is sunk

Your "20% underwater" point is true for the money already spent. It tells a new buyer nothing. Going forward, the same $4.71B retires about 69M shares at $67.85 (1.67% of the count) versus about 55M at $85 (1.33%). If you think the stock is heading to $58, you should want management buying more aggressively, not less. The reasonable objection is to pace, since a Q3 buyback of $4.7B again would take cash below $9.1B. I agree that is a watch item.

On funding, TTM buybacks of $9.9B still left net debt $1.07B lower than a year ago ($6.28B to $5.21B). The Q1 gain helped, but a one-time cash windfall returned to shareholders is not value destruction, and coverage is 24x.

3. The comp is about optics, and the optics change in Q3

You're right that the sequential margin recovery (24.5% to 32.3% to 33.4%) is old news. The year-over-year view is different. Q1 and Q2 were measured against stronger year-ago quarters, and Q2'25's margin was 34.1%. That is why the print shows only +11% operating income growth and "margin down 70 bps." Q3 and Q4 are measured against 28.2% and 24.5%. If Q3 lands at 32-33%, the headline flips from "margin down year over year" to "operating income up 25-30%." Markets know the comps, so I'm calling this an optics catalyst, not a fundamental one.

"A good-looking print got sold twice" assumes the 4/17 and 7/17 gaps were earnings reactions, which neither of us can confirm. Even if they were, the numbers we see now were fine, so the selling must have come from guidance or expectations, which aren't in our data. That cuts against the idea that the statements themselves are the problem.

4. Valuation and your $58 target

Your 26-27x normalized P/E uses a trailing base that includes Q4'25's 24.5% margin quarter ($0.56 EPS). Forward earnings start from a higher level, so the PEG of 2.4 overstates the multiple. Run-rate EPS of $3.08-3.20 gives 21-22x. Your 18x target needs the market to value a 13% grower with 33% operating margins and a falling share count at a lower multiple than today's. What is the case for that, other than momentum?

5. Insiders and the 9/18 gap

I'll give you insiders. Zero open-market buys is a fact, but it's also the base rate for a company paid largely in options, and a pause in Hastings's sales could mean anything. I'm giving it low weight in both directions.

The 9/18 gap deserves a straight answer. Neither of us can name the cause. You read it as the market knowing something the statements don't show. That is possible, but it is an argument from ignorance, and the same logic applies to the unexplained Q1 gain. That gain is the one with visible effects, and they are cash in, no new debt, and no liability growth. I'd treat the gap as a reason to size smaller and to identify the catalyst before Q3, not as evidence of impairment. If it turns out to be a disclosure that changes my numbers, I revise.

Your question: Q3 delivers the margin and the stock gaps down anyway

My plan is to size for the gap and diagnose before acting.

1. Size for a 10% gap. That means sizing the position so a gap to about $61 is an acceptable loss. I'd also buy in two parts, some now and the rest after the print, so I'm paying for information instead of guessing.
2. Treat $65 as a review trigger, not an exit. You're right that it can't protect a gap. Thesis exits are fundamental.
3. If margin hits but FCF misses or buybacks outrun FCF again, that is your cash thesis confirmed, and I cut.
4. If margin and FCF are fine and the stock gaps down anyway, I'm looking at a multiple still compressing. At about $62 that would be roughly 19-20x run-rate. I'd hold, add only if I can identify the cause, and not average down blind.

Where we agree

We now agree on the test. It is Q3 FCF, buybacks versus FCF, and opex growth versus revenue growth.

• Cash thesis intact: FCF roughly $2.3-2.7B or better, with buybacks at or below FCF. That is my judgment, not a derived number. Your $2.66B bar is the strict version.
• Cash thesis broken: FCF under about $2B, content ratio at or above 1.15x again, and buybacks still outrunning FCF.
• Still unknown: the earnings date, the 9/18 cause, and sentiment, because the feeds were empty.

The stock has fallen 37% on a business that grew 13%. The cash lines are the legitimate worry, but a working-capital-neutral quarter would put FCF back above the Q3'25 bar. The market is pricing the bear outcome with no sign yet that it is arriving. Bull Analyst: # Bull Rebuttal: Locking the Test Before the Print

You've moved me on several points, so I'll start there and then answer your question directly.

What I concede

• Your 34x was not a Q2-drain extrapolation. It was EV over normalized TTM FCF. I misread it.
• 25x is a fair price, not a discount. I'm withdrawing "priced for the cash test to fail." A mid-20s cash multiple on a 11-13% grower is full.
• My drain-adjusted $2.83B against an unadjusted $2.66B bar was apples to oranges. Q3'25 converted 82% of operating income into FCF, the best of the five quarters. It may have had a favorable working-capital swing, but I can't see it.
• The thresholds drifted. $2.3B as "intact" was too loose.
• The net debt direction is yours. Strip the Q1 item and net debt is roughly $8.0B against $6.28B a year ago. That is about 0.56x TTM EBIT, which is still low, but it isn't "lower."
• A first tranche of half the position isn't hedged.
• The 32-33% Q3 margin is an assumption. If H2 is seasonally heavier, the easy comp disappears, and the data can't rule that out.

Where I still disagree

1. The 34x versus 25x gap is the margin question. TTM operating income ($14.4B) includes the 28.2% and 24.5% margin quarters, while Q2 annualized is $16.8B. Two rough routes give a run-rate cash multiple of about 25-27x: - Q2 FCF with the working-capital drain added back is $2.83B, or $11.3B annualized, which is about 25x EV. - Q2 operating income annualized, less the annualized content overspend ($0.66B a quarter, inferred), taxed at about 18% and less capex, is about $10.7B, or about 27x.

So 34x holds only if margins slide back toward Q3'25-Q4'25 levels. That is the same test as before, now stated for the P&L as well as for cash.

2. The 7% EPS growth rests on an assumption. It requires Q2'25 to have had a tax rate near Q1'26's 19.3%, and we don't have that line. What we do have: net income was 83% of operating income in Q2'25 and 81% in Q2'26. A lower Q2'26 tax rate did not improve that ratio, and Q2'26 pretax income ($4.07B) was $0.12B below operating income. The tax rate may not have flattered the year-over-year comparison at all. A PEG near 2 is more defensible than near 3, though still not cheap.

3. The +26% content cash spend is a base effect. Q2'25's $3.93B was the low point, with a 1.03x ratio. Against the four-quarter average of $4.73B, Q2'26's $4.97B is about 5% higher. That is still worth watching, but it doesn't show a runaway.

4. The multiple band is observable. On Sept 2 the stock was $82.73, about 26-27x run-rate EPS, on the same financial statements we have today. Since then it has fallen 18% with no new filing. Either the market learned something I can't see, which is your 9/18 argument, or the multiple is compressing on its own. That is why I want the cause identified before I add.

Your question

Operating income up 25-30% with FCF near $2.3B is amber, leaning negative. It is not thesis-confirming.

That outcome means FCF conversion falls from 82% to the mid-50s%, so the margin win would be real at the EBIT line without showing up in cash. It would be better than Q2's 37% conversion, but still 14% below the year-ago FCF. I'd freeze adds. What I do next depends on the cash flow statement: - If the shortfall is working capital and the content ratio is at or below about 1.10x, I hold. - If the content ratio is at or above 1.15x again, that is your thesis and I exit.

Thresholds, locked before the print:

Q3 outcome	Verdict	Action
FCF ≥ $2.66B, buybacks ≤ FCF, operating margin ≥ 31%	Intact	Complete the position
FCF $2.0-2.66B	Amber	No adds, hold the starter, read the drivers
FCF < $2.0B, or content ratio ≥ 1.15x with buybacks > FCF, or operating margin < 30%	Broken	Exit

The 31% and 30% margin lines are my judgment. They sit between Q3'25's 28.2% and the 32-33% of Q1 and Q2.

Plan changes

• Size the first tranche as a starter, about a third. I'd size it so your $58 case (-15%) is a loss I can absorb without changing decisions. The rest goes in after the print, and I accept that I may pay more if the print is good.
• Tighten the $65 rule. A close below $65 means no more adds and cutting the starter by half unless the cause is identified. You're right that this can't protect against a gap, so sizing does that job. The rule limits what happens on the days after.

Risk/reward on your numbers

Your illustrative 18x gives $58, or -15%. The Sept 2 multiple of about 26x on run-rate EPS gives about $83, or +22%, which is also near the 200 SMA at $84.20. On those two endpoints alone, the trade works if the upside case happens about 41% of the time or more. That is illustrative arithmetic, not a probability estimate. Your 18x needs new information to be priced in, and mine needs the print to deliver.

I don't claim the trend is wrong. All three SuperTrend tiers are down and I'd wait for confirmation before sizing up. The disagreement is over what the first dollar should risk before the information arrives, and a starter position answers that better than half.

Still unknown

The earnings date, the 9/18 cause, what the Q1 $2.85B item was, what drove the Q2 accrual drain, and anything about sentiment. Bull Analyst: # Bull Final: Buy the Print, Not the Tape

We've narrowed this a lot. Here is what I concede, where your closing math is off, and what I'm changing.

What I concede

• My table, run on history, is unflattering. Q2'26 trips two Broken conditions, and no non-windfall quarter on reported FCF clears every Intact row.
• The cash multiple is full. Your route-two at a 31% margin gives about 30x EV. Adding back roughly $0.5B a year of SBC, which is standard in FCF, gets about 28x. I'm not calling that cheap.
• The tape is evidence. All three SuperTrend tiers are down, ADX is 34.9, and OBV is at a window low. That argues against sizing up on hope.
• Opex belongs in the table. Q2 opex was 18.5% of revenue against 17.9% a year ago, which explains essentially all of the 70 bps YoY margin decline.

Where your closing math is off

1. "Intact needs 82% conversion" is wrong. The $2.66B bar is a dollar figure from Q3'25, when operating income was $3.25B. On Q3'26 operating income of $4.1–4.3B, the same $2.66B needs only about 62–65% conversion. Your series is 60%, 82%, 63%, 58% and 37%. Q4'25's 63.2% sits right on the line, since 63.2% × $4.25B is $2.69B. Your own central estimate of about $2.5B is roughly 6% under the bar, inside the noise of a series that spans 37–82%. On the FCF line alone, Intact is neither a long shot nor a foregone amber.

2. The Q1 ex-item figure is a range. Your ~$2.3B assumes the full $2.85B pre-tax item arrived in cash with no cash tax. If tax at about 19% (~$0.55B) was paid in the quarter, ex-item FCF is closer to $2.8B. That is 71% conversion, and Q1'26 would clear my bar with a 32.3% margin and buybacks of only $1.27B. Cash taxes paid aren't in our data, so the honest figure is $2.2–2.8B, not a point estimate.

3. Seasonality is testable, and your Q3 arithmetic assumes it away. Gross margin was 51.9% in Q2'25, Q1'26 and Q2'26, and about 46% in the two quarters between. Your Q3 scenario uses 51.9%. If the dips were seasonal, Q3 prints near 46%, operating margin falls below 30%, and my own table says Broken and I exit. Five quarters can't settle it for either of us, but the print will.

4. On opex, I'll set the gate from observed data, not convenience. "Opex growth ≤ revenue growth" fails at Q2 already (17.7% vs 13.4%). It would also label your own +31% operating-income scenario as not intact, so it tests for cost-cutting, not for whether margin holds. In that scenario, gross margin lapping 46.4% is worth about +550 bps and opex deleverage costs about 80 bps, so gross margin is the swing factor and opex is the second-order watch item. I'll use no acceleration from Q2's 17.7% for Intact, and above 20% as a Broken trigger. Both are judgment calls.

The starter: you're right, and I'm changing the plan

Intact needs four things at once: FCF, buybacks, margin and opex. Even with FCF near its median, that is a minority outcome. A starter only pays in that case. In amber it holds a position with no new information, and in broken it eats the gap. I also said I wanted the 9/18 cause before adding, and a pre-print starter contradicts that. So I'm dropping the pre-print buy for new money. I'm keeping the thesis and moving the entry to the print.

Rule: any Broken trigger gives Broken, all four Intact conditions give Intact, and everything else is Amber.

Verdict	Conditions	Action
Intact	FCF ≥ $2.66B, buybacks ≤ FCF, operating margin ≥ 31%, opex growth ≤ 18%	Buy the full position
Amber	Anything else	Read the cash flow statement. If the shortfall is working capital only, content ratio ≤ 1.10x and buybacks ≤ FCF, buy half. Otherwise stay out.
Broken	FCF < $2.0B, or content ≥ 1.15x with buybacks > FCF, or operating margin < 30%, or opex growth > 20%	Stay out, or exit if held

If someone already holds, a close below $65 means no adds and halving the position unless the cause is identified.

Why I won't wait for the tape

Your re-entry needs a close above 71.09 and then a SuperTrend flip above 74.86, which is +4.8% and +10.3% from $67.85. For this thesis the print is the information, because it settles cash conversion, margin and opex. The SuperTrend flip lags it. If the print is Intact and the stock gaps up, I pay more. If it isn't, I never owned it. I accept that cost, and I think it is smaller than the 10%+ premium that trend confirmation costs.

Where the bull case stands

• The business is sound. Revenue is +13%, gross margin is steady at 51.9%, operating margin is 33.4%, interest coverage is about 24x, and the share count is down about 2%.
• The price has reset. The stock is 37% below its April 16 close while the business kept growing. At roughly 28–30x cash on Q2-based run-rates it is a fair price, not a bargain. The bull case is that a fair price for a 12–13% compounder after a derating is acceptable once the cash-conversion question is answered.
• The open question is narrow. It is whether FCF conversion reaches about 63%, whether buybacks stay within FCF, and whether gross margin holds near 51.9%. Each is a live outcome, not a long shot, and one print resolves all three.

Still unknown

• The earnings date.
• The cause of the 9/18 gap.
• The nature of the Q1 $2.85B item and the cash taxes paid on it.
• What drove the Q2 accrued-expense drain.
• Sentiment, since the feeds were empty.

If Q3 comes back Broken, I'm out and your bear case was right. If it's Intact, the stock was a good business that got cheaper than its fundamentals justified. Bull Analyst: # Bull Close: One Line Item Separates Us

Your closing moved the process a long way, and I'll concede the points that hold before narrowing what's left.

What I concede

• Pooled H1 conversion is below the bar. Ex-item H1 FCF is $3.77-4.32B, or 46-53% of $8.15B of operating income. The bar needs 62-65%. I'll take your central Q3 estimate of $2.5-2.6B as roughly a coin flip against $2.66B, leaning short. "Live outcome" was too generous.
• "Intact" tolerates a 15% two-quarter decline. Q2+Q3 at exactly $2.66B is $4.19B against $4.93B a year ago. That's a real hole.
• My buyback row contradicts my own argument. I said buying at lower prices is more accretive, then failed the quarter for doing it.
• The table had no price ceiling and no 9/18 condition. Both were inconsistent with what I'd said.
• I accept the amber tightening in principle. I only want it tied to a number rather than a story (see 2 below).

1. The gap between us is one line item

Add Q2's $1.25B accrued-expense drop back to your pooled H1 range and you get $5.0-5.6B, or about 62-68% of H1 operating income. That is the bar. This is my arithmetic, and it assumes Q1's working-capital change was neutral, which I can't see. If the drain was timing, true conversion sits near the bar. If it's structural, it sits near your 50%. We disagree about that one line, and Q3's cash flow statement shows it.

2. Reported FCF can be gamed by a rebuild, so test both

You said the cash flow statement "won't show whether that line reverses." It won't show a future reversal, but it will show whether one happened in Q3. A rebuild also cuts the other way. If $1.25B flows back, Q3 FCF passes $2.66B even if underlying conversion is about 48%. So I'm adding a pre-working-capital test, computed from reported lines rather than a narrative. It is $2.3B, or about 54% of $4.25B, which is no worse than your H1 best case of 53%. That is my judgment, anchored to your table.

3. Buyback row: fixed, and looser on purpose

Replace "buybacks ≤ FCF" with net debt at 9/30 ≤ $7.0B, up from $5.21B at 6/30. That is about 0.5x TTM EBIT and keeps cash near $7.3B with debt flat, against $2.48B due within a year. A repeat of Q2's $4.71B buyback passes only if FCF is about $2.9B or more. It is a loosening, and I'm saying so. You're right that the buyback is a management choice, so the row now guards the balance sheet instead of policing the decision.

4. Price ceiling: I won't pay up

On your SBC-adjusted base of about $10.2B ($9.7B + $0.5B), I'd pay at most ~30x EV. That is roughly $72 per share on today's base. I'd recompute with Q3 actuals, since a better quarter raises it. Your gap-up objection lands here. An Intact print that gaps to $75 means I wait. The ceiling sits next to your 71.09, so on today's numbers we'd buy at about the same level.

Where I still differ

• The SuperTrend flip. I won't require a +10% trend flip as an entry condition. The ceiling keeps me from overpaying, and the print answers the cash question sooner than a lagging indicator.
• Amber isn't automatically "stay out." If reported FCF misses, pre-WC FCF is at least $2.3B, the content ratio is at or below 1.10x and the other rows pass, the shortfall is measurable rather than asserted. I'd buy one-third in that case.
• Intact is a minority outcome. Four or five rows have to clear together, so I agree it's well under half. The expected payoff comes from verifying the cash question before paying, not from beating the odds.

Locked table

Verdict	Conditions	Action
Intact	Reported FCF ≥ $2.66B; pre-WC FCF ≥ $2.3B; net debt ≤ $7.0B; op margin ≥ 31%; opex growth ≤ 18%; price ≤ ~30x ceiling (~$72 today)	Buy one-third. Add the rest on a close above 71.09 or an identified benign 9/18 cause, still under the ceiling.
Amber	Not Intact, not Broken	Stay out. Exception: the pre-WC test above, with one-third.
Broken	FCF < $2.0B, or op margin < 30%, or opex growth > 20%, or content ≥ 1.15x with net debt > $7.0B	Stay out, or exit if held.

If an Intact print is followed by a decline and 9/18 is still unexplained, I won't average down blind. A close below $65 means no adds.

Where the bull case stands

At $67.85 the stock is about 28x SBC-adjusted run-rate cash earnings. That is a fair price for a 12-13% grower with 33% operating margins, a shrinking share count and low leverage. I'm not arguing for a re-rating to $83. The case is that a business compounding at that pace doesn't need a discount if cash conversion holds. The next print answers that, and I'd rather wait for it than argue it.

If Q3 comes back Broken, I'm out and the cash lines were the right worry. If it comes back Intact under the ceiling, I'll have bought a good business at a fair price after it had already fallen 37%.

Still unknown: the earnings date, the 9/18 cause, the nature of the Q1 $2.85B item and the cash taxes on it, what drove the Q2 accrual drain, and sentiment, since the feeds were empty.

Bear Researcher

Bear Analyst: # The Bear Case for NFLX: Cheaper Isn't the Same as Cheap

You asked what explains the gap between price and fundamentals. The gap is smaller than your table suggests, and some of it is the market reading the cash lines instead of the EPS line.

1. Your valuation leans on the flattering metric

You anchor on 20x EV/EBIT. But cash content spend is running ahead of amortization ($4.97B vs $4.31B in Q2, 1.15x vs 1.03x a year ago), so EBIT overstates what's left. On a cash basis:

	Your framing	Cash framing
Valuation	~20x EV/TTM EBIT	~34x EV/normalized FCF ($8.3B)
FCF yield	"3-4%"	~2.9% adjusted, ~2.2% on Q2 annualized
H1 buybacks vs FCF	$5.99B vs $6.62B (90%)	$5.99B vs ~$3.8B (~160%)
TTM buybacks vs FCF	$9.9B vs $11.15B	$9.9B vs ~$8.3B

You said you're not leaning on the Q1 gain, but your H1 buyback defense does. H1 FCF only exceeds buybacks because it includes the ~$2.8B item the fundamentals report flags as probably one-time. Q1's cash pile was that gain, and management spent it in a single quarter.

I estimate Q2 buybacks were done at prices averaging somewhere in the $80s, based on insider-sale prices. That puts them roughly 20% underwater today. Buying "more at lower prices" isn't accretive when prices keep going lower. About $8B over three quarters retired just 1.7% of the shares.

I'll concede there's no solvency issue. Net debt is low and coverage is 24x. The problem is capital allocation, not survival: cash fell from $12.26B to $9.10B, with $2.48B of debt now due within a year.

Your normalized P/E of 26-27x on 11% EPS growth is a PEG around 2.4. That's a full multiple for a company whose margins are moving the wrong way. Q2 EPS was also helped by a 16.4% tax rate versus 19.3% in Q1. At the Q1 rate, EPS would be about $0.77, not $0.80.

2. The "easy comp" has already played out twice

Operating margin was 32.3% in Q1 and 33.4% in Q2. The recovery from Q3'25's 28.2% is old news, and the stock still fell from $107.79 to $67.85 across both prints.

The two heavy-volume gaps (4/17 and 7/17) match the usual reporting calendar. 4/17 was -9.7% on 126M shares, and 7/17 opened at $65.48 on 142M. The tools don't confirm these were earnings reactions, but the timing is hard to ignore. A good-looking print got sold twice.

On the metric you call the number to watch, the comp is harder, not easier. Q3'25 FCF was $2.66B against Q2'26's $1.53B, so Q3 needs roughly +74% sequentially just to be flat. That requires the whole $1.3B working-capital drain to reverse and the content cash overspend to stop widening. That is your best case, and it's your own kill criterion #2.

The cost line also cuts against you. Opex is up 17.7% against revenue up 13.4%, so operating income grew 11.1% and net income only 8.8%. EPS reached +11.3% because of the buyback. Netflix's premium was a margin-expansion story, and margin is now down year over year. "Only 70 bps" is still the wrong direction.

3. The technical risk/reward compares mismatched endpoints

Your 6:1 ratio sets the nearest support (-4%) against the farthest resistance (the 200 SMA, +24%). Like for like, $65.08 is -4.1% and the daily SuperTrend at $74.86 is +10.3%. That's about 2.5:1 before slippage, with the 10 EMA, the September gap zone and the 50 SMA in the way.

The downside isn't tight either. Gap days have been 5-10%, and a 5-10% gap from here lands at $61-64, through every support you listed. Your own invalidation level of $65 is about 4% away, and a gap would fill you below it.

On the bounce, the 22% rally from $67.60 to $82.73 has been 98% retraced. Your exhaustion signals are also thinner than they look: - Only the daily TD-9 is complete. Weekly is +4 and monthly is +5, so both are unfinished. - RSI is 32.45, above 30, and the z-score is -1.61, short of -2. - OBV is at a window low with no divergence, and the MACD histogram is still falling. - ADX went from 9 to 35 in two weeks, so this is a brand-new trend, not an exhausted one.

July 17 was bought, and then it was sold again.

4. Insiders and the tape

The right comparison isn't $13M against a $282B market cap. It's zero open-market buys in 16 months of records, through a 49% drawdown. Sarandos sold $9.7M at about $73 and Peters sold $2.0M at $73.54, both in early August, after the July low. Grants are compensation, not conviction. Hastings sold $33-45M a month for seven straight months, and a pause could just be a plan ending.

On Gundlach, you say NFLX isn't crowded, but your report has no positioning data because the sentiment feeds were empty. The same headlines show tech and AI names rallying (Accenture, IBM, Micron). They're headlines only, but they suggest NFLX's slide is stock-specific rather than macro.

5. The gap you can't explain

On 9/18 the stock opened 5.4% lower on 114M shares with no known cause. You admit you can't explain it, and neither can I. But you treat it as noise because the financials through June 30 look fine. I treat it as the market acting on something that isn't in a June 30 statement.

There's also the unidentified $2.85B Q1 item and the $586M acquisition. When one-time items and heavy-volume gaps go unexplained, "the reported numbers show no problem" is a lagging indicator.

Where I concede, and what I think happens

Revenue growth is real, the balance sheet is sound, and this isn't a broken business. My view is that the stock still has downside before it offers a better entry. If the market settles at 18x Q2 run-rate EPS ($3.20), that's about $58, or -15%. That's illustrative, not a forecast.

What would make me wrong: - A close above 71.09, then a daily SuperTrend flip above 74.86. - Q3 FCF at or above $2.66B with buybacks at or below FCF. - Opex growth at or below revenue growth.

My question for you: your kill switch is 4% away. If Q3 delivers the 32-33% margin you expect and the stock gaps down anyway, as it did after the last two prints, what's the plan? Bear Analyst: # Bear Rebuttal: The Best-Case Cash Multiple Is 25x, and That Isn't "Priced for Failure"

I'll concede first, because some of your points land.

What I concede

• Content spend is lumpy, not a steady trend. The ratios you listed (1.03x, 1.12x, 1.02x, 1.09x, 1.15x) match my own arithmetic on the inferred line, and TTM is about 1.09x. I overstated "trend."
• Sunk cost is sunk. My "20% underwater" point says nothing about what a new buyer gets at $67.85.
• A working-capital-neutral Q3 plausibly clears $2.66B. On Q2's economics, $2.83B is a reasonable base case. I disagree on how much weight "neutral" deserves, not on the math.
• Insiders carry low weight in both directions. Agreed.
• The comp is optics. You've dropped "catalyst." I'll come back to why that matters.

1. You misread my 34x

The 34x was EV over normalized TTM FCF of $8.3B. It does not assume Q2's drain repeats. TTM already contains four quarters of real working-capital swings. The Q2-as-reported annualized figure ($6.1B) would be about 47x.

Your 25x is the best single case: Q2 with the whole drain added back. Two problems: - You adjust Q2 for working capital but compare it to an unadjusted Q3'25 bar of $2.66B. We can't see what Q3'25 working capital did. - A drained accrual that "doesn't repeat" is still a guess. We don't know what drove it.

Even if the 25x holds, a ~4% FCF yield on a 11–13% grower is a fair price. It is not a stock "priced for the cash test to fail." Your own table doesn't show a failure multiple.

The trend claim is weaker, but one stat survives. In Q2, inferred cash content spend rose about 26% year over year ($4.97B vs $3.93B), against revenue of +13.4% and amortization of +12.5%. That line is inferred, not confirmed.

2. Buybacks: pace and funding

Your arithmetic is right: the same $4.71B retires about 69M shares at $67.85, versus about 55M at $85. My objection is to the pace and the funding.

• Net debt "$1.07B lower than a year ago" leans on the windfall. Strip the roughly $2.8B Q1 item (pre-tax, inferred) and net debt would be about $8.0B against $6.28B, or roughly $1.7B higher. Returning a windfall isn't value destruction, but it can't be repeated.
• Recurring FCF is about $8.3B. TTM buybacks were $9.9B, and Q2's pace annualizes to about $18.8B.
• Illustratively, if Q3 FCF is $2.5B and buybacks repeat at $4.7B, cash falls to about $6.9B, with $2.48B of debt due within a year.

I'm not arguing management should buy less because the stock is falling. I'm saying a buyer that put $4.7B to work at prices I estimate were in the $80s, at 3x FCF, isn't showing price discipline. The buyback is not a margin of safety.

3. Why "optics" doesn't carry the thesis

The stock fell through two prints in which margin recovered from 24.5% to 32.3% to 33.4%. You say the selling "must have come from guidance or expectations, which aren't in our data." I agree, but that undercuts you. If the market trades the forward view we can't see, a favorable year-over-year comp doesn't answer it.

Two more caveats on the 32–33% Q3 assumption: - It treats the Q3'25 and Q4'25 dips as one-offs. The report doesn't say what caused them. If H2 carries seasonally heavier cost, the "easy comp" flips. - Q1'25 isn't in our data, so "Q1 was measured against a stronger year-ago quarter" is unverified. Only Q2's 34.1% is.

4. Your question: what's the case for 18x?

1. Quality of EPS growth. At Q1's tax rate, Q2 EPS was $0.77, up about 7% year over year (assuming Q2'25's tax rate was as reported). That is helped by a roughly 2% lower share count. 22x on about 7% growth is a PEG near 3.
2. No anchor says 22x is a floor. At $133 on Q2'25 annualized EPS ($2.88), the multiple was in the mid-40s. It has already halved, and ADX at 35 says the move is still active.
3. Negative operating leverage. Opex is up 17.7% against revenue up 13.4%, with R&D up 22%.
4. Your own plan uses my number. You call $62 "roughly 19–20x run-rate" and say you'd hold. 20x on $3.08–3.20 is $62–64, and 18x is $55–58. I called 18x illustrative, but your downside case already sits next to it.

5. The plan and the thresholds

Your plan is more careful than a stop-loss, but it has gaps.

• The first tranche takes the gap without information. If you are "paying for information" and need the 9/18 cause identified before adding, the logic says buy after the print. Buying half now isn't hedged.
• No price can prove the thesis wrong. $65 is a review, $61 is a hold, and $58 is a hold. Against a trend with all three SuperTrends down and OBV at its window low, that isn't risk control. It's a thesis that can only fail on a fundamental print, which may come after a 10% gap.
• The thresholds moved. You first called $2.66B the bar. Now "intact" is $2.3–2.7B or better. $2.3B is about 14% below Q3'25's FCF, in a quarter where you expect revenue up 12–13%. The gap between $2.0B and $2.3B is undefined.

Where this leaves us

We agree on the test: Q3 FCF, buybacks versus FCF, and opex growth versus revenue growth. We also agree there is no solvency issue and that revenue growth is real. The Q3 date, the 9/18 cause, the Q1 item and sentiment are all still unknown.

My view: even your best-case cash multiple isn't a discount, the trend is confirmed, and the first dollar buys the gap risk before the information arrives.

What would change my mind (unchanged): - A close above 71.09, then a daily SuperTrend flip above 74.86. - Q3 FCF at or above $2.66B with buybacks at or below FCF. - Opex growth at or below revenue growth.

My question back: if Q3 operating income comes in up 25–30% year over year, as you project, but FCF lands near $2.3B (down about 14%), does your plan call that thesis-confirming or thesis-breaking? That divergence is exactly the cash-conversion problem I'm arguing about. Bear Analyst: # Bear Closing: Your Own Table Says the Last Print Was a Sell

Several of your points hold up, so I'll concede them first and then say where I still disagree.

What I concede

• The EPS growth point. Net income was 83% of operating income in Q2'25 and 81% in Q2'26, so I can't show that the tax rate flattered the year-over-year comparison. I'm dropping "7% growth, PEG near 3." PEG near 2 is the defensible figure.
• The +26% content spend. Against the four-quarter average of $4.73B, Q2'26's $4.97B is about 5% higher. That is a base effect, and I'm retiring it.
• 25-27x on a Q2 run-rate is a fair-price range. We both say it isn't a discount.
• Your table and a one-third starter are real improvements. Locking thresholds before the print is what I asked for.

1. Run the last five quarters through your table

Quarter	FCF	Buybacks	Op margin	Verdict
Q2'25	$2.27B	$1.65B	34.1%	Amber
Q3'25	$2.66B	$1.86B	28.2%	Broken (margin <30%)
Q4'25	$1.87B	$2.08B	24.5%	Broken
Q1'26	$5.09B reported (~$2.3B ex-item, rough)	$1.27B	32.3%	Intact as reported, Amber ex-item
Q2'26	$1.53B	$4.71B	33.4%	Broken (FCF <$2.0B, content 1.15x with buybacks > FCF)

Without the Q1 windfall, no quarter in our data clears your "Intact" row. The latest reported quarter trips two separate "Broken" conditions, so you're initiating a position in a stock whose most recent print would trigger your exit. Two caveats: the Q1 ex-item figure is a rough estimate, and Q3'25 fails only on the margin rule, which is regime-specific.

The central case lands in amber. Non-windfall FCF-to-operating-income conversion across the five quarters is about 60% (60%, 82%, 63%, 58%, 37%). Applied to your $4.1-4.3B Q3 operating income, that gives about $2.5B. "Intact" needs the best conversion in the dataset, 82%, to repeat. In your own framework the likely result is "no adds, hold, read the drivers," which is a weak payoff for taking gap risk first.

2. The 25-27x multiple assumes Q2's margin is the run-rate

Q2's 33.4% is the second-highest of the five quarters. Last year the path went from 34.1% in Q2'25 to 28.2% and then 24.5%. If that pattern is seasonal, Q2 is the flattering base to annualize, and the data can't rule it out.

Apply your route-two method (annualized operating income, less the $0.66B quarterly content overspend, taxed at 18%, less capex) at your own 31% "Intact" threshold. On $50.2B of annualized revenue that gives about $9.7B of cash earnings, or roughly 30x EV. Even a passing print leaves the stock near 30x cash at today's price, on the same static basis you used.

Route one needs a $2.83B FCF quarter. No non-windfall quarter in the dataset exceeded $2.66B.

3. Your table dropped the opex test

We both listed opex growth versus revenue growth as a test, and then it disappeared from the table. In Q3 it matters, because the margin recovery will come from gross margin lapping Q3'25's 46.4%. Here is my arithmetic:

• Revenue is +12.5% to $12.95B.
• Gross margin is 51.9%, which gives gross profit of $6.72B.
• Opex is +17.7% (Q3'25 opex was $2.10B, derived), which gives $2.47B.
• Operating income is about $4.25B, a 32.8% margin and +31% year over year.

That print passes your margin row while the cost line keeps deleveraging, with opex still growing faster than revenue. Please add opex growth back as a fourth row.

4. The endpoints and the starter

You say my 18x case "needs new information." But from Sept 2 to Oct 1 the stock fell 18% on no new filing, and a further 15% fall to $58 is smaller than that. Your $83 is roughly a full retrace of that same move. Both endpoints sit inside one month's realized range, so the 41% breakeven can't be settled by arithmetic. What breaks the tie is the tape:

• ADX is 34.9, and all three SuperTrend tiers are down.
• OBV is at a window low with no divergence.
• The 22% bounce was fully retraced.
• All three heavy-volume gaps in the window were to the downside. Their causes are unconfirmed, and the tape is evidence, not proof.

You also say you want the 9/18 cause identified before you add, yet the first third goes in before it is. Sizing for a 10% gap makes that survivable, but it doesn't buy information.

Where I land

• Don't initiate ahead of the print. The cost of waiting is paying up if Q3 clears all four rows, which is a minority case on this history. The benefit is not holding through a gap in the amber and broken cases.
• Turn constructive on evidence: a Q3 that passes FCF, buybacks, margin and opex, plus a close above 71.09 and then a daily SuperTrend flip above 74.86.
• If you already hold, the 71-75 gap zone is the place to reduce.

The bull case has narrowed to this: the business is sound and the multiple has compressed. I agree with both. Compression can continue while the cash lines stay unconvincing, and the next print is more likely to land in your amber row than your green one.

What would make me wrong (unchanged): - A close above 71.09, then a daily SuperTrend flip above 74.86. - Q3 FCF of $2.66B or more with buybacks at or below FCF. - Opex growth at or below revenue growth.

Still unknown: the earnings date, the 9/18 cause, the Q1 $2.85B item, what drove the Q2 accrual drain, and sentiment, since the feeds were empty. Bear Analyst: # Bear Close: You Moved the Entry, but the Table Still Leaks

Moving the entry to the print was my main ask, and I'll credit it. A few of your corrections also land, so I'll concede those before pressing on what's left.

What I concede

• "82% conversion" was the wrong way to state the bar. $2.66B on $4.1-4.3B of operating income needs 62-65%, and Q4'25's 63.2% sits right on that line. Retired.
• Q1 ex-item FCF is a range. Cash taxes on the item are not in our data.
• Your opex gate beats mine. "Opex growth ≤ revenue growth" fails at Q2 already. Opex deleverage (18.5% vs 17.9% of revenue) explains essentially all of the 70 bps decline, and gross margin is the swing factor. I'll use ≤18% for Intact and >20% for Broken.
• Seasonality is testable. Your exit if margin is below 30% is the right discipline.

1. Pool the quarters and the range narrows

Pooling H1 removes the question of which quarter the tax payment or the accrual swing landed in:

Case (my arithmetic)	H1'26 FCF ex-item	Per quarter	Conversion on H1 op. income ($8.15B)
~$0.55B tax on the item paid within H1	$4.32B	$2.16B	53%
Tax not yet paid	$3.77B	$1.89B	46%

Both are below the 62-65% your bar needs. If the tax is still unpaid, it lands in H2 and hits Q3 or Q4.

The cash roll-forwards also reconcile with no debt movement: - Q1 cash rose $3.23B, against FCF $5.09B less buybacks $1.27B less the $0.59B acquisition. - Q2 cash fell $3.16B, against FCF $1.53B less buybacks $4.71B.

That is consistent with the item being real cash.

My central Q3 estimate is unchanged. TTM normalized FCF of $8.3-8.85B is 58-61% of TTM operating income, which gives about $2.5-2.6B. I agree that's inside the noise of your $2.66B bar. The FCF row alone is roughly a coin flip, slightly leaning short. If the $1.25B accrual drop rebuilds, Q3 clears easily and I'll say so.

2. "Intact" tolerates a 15% decline

At exactly $2.66B, Q2+Q3 FCF is $4.19B against $4.93B a year ago (Q2'25 $2.27B + Q3'25 $2.66B). That is down 15% over two quarters while revenue grows 12-13%.

This matters most for your Amber rule, "buy half if the shortfall is working capital only." At the print, the cash flow statement will show an accrued-expenses line. It won't show whether that line reverses. Every FCF miss can be explained as working capital after the fact, so I'd tighten the rule. If Amber comes from FCF under $2.66B, don't buy half on that story. Wait one quarter for the accrual rebuild to show up. That costs a quarter, but you wouldn't be paying for an unverified explanation.

3. The buyback row conflicts with your own argument

You argued that $4.7B retires about 69M shares at $67.85 versus 55M at $85, and that if I think the stock is heading to $58, I should want management buying more. The table then fails the quarter if buybacks exceed FCF. Both can't hold.

At $68, with Q2's pace as the precedent, the likeliest management behavior is to keep buying. So that row is decided mostly by a capital-allocation choice, not by business quality. You already agreed that Intact is a minority outcome. The buyback row is why I think it's a smaller minority than the FCF row alone suggests.

4. The table has no price ceiling and no 9/18 condition

• You said you wanted the 9/18 cause identified before adding. "Intact: buy the full position" has no such condition.
• There's no price limit. Your thesis is a derated multiple, and you now call 28-30x cash fair. If an Intact print gaps to about $75, that's roughly 31x on your SBC-adjusted base. $75 is also about where my re-entry sits (daily SuperTrend at $74.86, +10.3%). In the gap-up case, we buy at the same price, and your argument that waiting for the tape costs more than the print goes away.
• The real difference is the other case. Suppose the numbers look good and the stock falls anyway. Neither of us can confirm the 4/17 and 7/17 gaps were prints, but if they were, this already happened twice. Under your table you'd then buy a full position into ADX 35, three SuperTrend tiers down, and an unexplained gap.

My amendment is one-third on an Intact print and the rest on a close above 71.09 or an identified 9/18 cause.

Where I land

• Don't initiate before the print. We now agree on this.
• After the print, engage only on Intact and stage the entry. Amber and Broken mean stay out.
• If you already hold, reduce into the 71-75 gap zone. A close below $65 means no adds at minimum.
• The core bear view is narrower than where we started. The business is sound, but the price is fair, not cheap. Cash conversion is unproven. A stock that has halved can still compress further, and the tape (ADX 34.9, OBV at a window low, all three SuperTrend tiers down) is still pointed down.

What would change my mind: - Q3 FCF of $2.66B or more with buybacks at or below FCF, and a cash flow statement showing the accrual drop rebuilding. - Opex growth at or below 18%, using your gate. - A close above 71.09 and then a daily SuperTrend flip above 74.86, or an identified, benign cause for 9/18.

Still unknown: the earnings date, the 9/18 cause, the nature of the Q1 $2.85B item and the cash taxes on it, what drove the Q2 accrual drain, and sentiment, because the feeds were empty.

If Q3 comes back Intact and the tape agrees, the bear case was wrong. Until then, the better order is to let the print come first, as you now propose, and to make the table strict enough that a story can't stand in for the cash. Bear Analyst: # Bear Final: The Table Is Close, but Four Leaks Remain

You moved the entry to the print, added a ceiling and loosened nothing without saying so. I'll concede what holds, then press the four places where the table still lets a story stand in for cash.

What I concede

• The pre-WC test inside "Intact" is a real fix. It closes the rebuild loophole I raised. If $1.25B of accruals flow back, a reported $2.66B could hide about $1.4B of underlying FCF, and your row catches that.
• Net debt is a better guard than "buybacks ≤ FCF." I argued buybacks are a management choice, and you stopped policing the choice.
• The SuperTrend flip is dropped as an entry condition. It lags the print. Your ceiling and the 71.09 trigger do that job, and I'll use 74.86 only as the line where I'd stop calling the tape bearish.
• We agree on the framing. No pre-print initiation, a staged entry, and a price of roughly 28x cash that is fair, not cheap.

1. The pre-WC bar is anchored to the wrong series

You set $2.3B (54% of $4.25B) as "no worse than your H1 best case of 53%." But my 53% was reported FCF, with Q2's drain still in it. Your own add-back puts H1 pre-WC at $5.0–5.6B, or 61–69% of operating income.

Applied to Q3, that implies pre-WC FCF of about $2.6–2.9B. The $2.3B bar sits 12–21% below your own range. It's the same adjusted-versus-unadjusted mismatch we both caught earlier. I'd set the bar at $2.5B, the low end of your own range.

2. The Amber exception rewards the line we can't verify

• The table and the text disagree. The text requires a content ratio of 1.10x or below and all other rows passing. The locked table says only "the pre-WC test above."
• The incentive runs the wrong way. Pre-WC FCF is reported FCF plus the drain, so a bigger working-capital drain makes the exception easier to pass. Q2 itself would clear it ($1.53B + $1.3B = $2.83B), and only the Broken row (FCF < $2.0B) stops it.
• My fix: use the text version, and add that Q3 must not show a second consecutive drain above about $0.3B (my judgment). One drain can be timing, but two in a row is a pattern.

3. The second tranche has almost no price window

The add trigger is a close above 71.09 and the ceiling is about $72. That is a window of $0.91, or 1.3%. An Intact print that gaps above $72 means no add, so in practice the second tranche depends on "an identified benign 9/18 cause." That phrase is undefined.

I'd define it as a named, public, company-specific event, addressed in the Q3 release or call, with a quantified effect that doesn't touch the FCF, margin or opex rows. Anything else is a story. If no cause is found, you hold one-third, and I think that is the honest outcome.

4. The content row can be neutralized by management

"Content ≥ 1.15x with net debt > $7.0B" can be defeated by trimming the buyback. I conceded a single 1.15x quarter is lumpy. But Q1 was 1.09x, Q2 was 1.15x, and a second straight quarter at 1.15x or higher would be a trend. I'd make that Broken regardless of net debt.

Proposed edits

Row	Your table	My edit
Pre-WC FCF (Intact)	≥ $2.3B	≥ $2.5B
Amber exception	Pre-WC test only	Pre-WC ≥ $2.5B, content ≤ 1.10x, other rows pass, no second drain > ~$0.3B
Second tranche	71.09 close or "benign 9/18 cause"	Same, with "benign" defined as above
Broken (content)	≥ 1.15x with net debt > $7.0B	≥ 1.15x for two straight quarters

Where I land

• The likeliest outcome is "no position." My central Q3 FCF estimate is $2.5–2.6B against a $2.66B bar. Intact needs FCF, pre-WC, margin, opex and price to clear together, so most paths end in Amber, and waiting costs little.
• If you already hold, trim above about $72. That is your own ceiling, the level where you say you wouldn't buy. A close below $65 means no adds.
• I'm not calling the business broken. Revenue growth is real, the balance sheet is sound and coverage is about 24x. My claim is that 28x cash earnings is a fair price, so there is no margin of safety, while the cash conversion question is still open and the tape (ADX 34.9, OBV at a window low, three SuperTrend tiers down) points down.
• Competition and subscriber saturation are not part of this. Our data has no subscriber, segment or competitor detail, so I'm not arguing from it.

What would change my mind: - An Intact print under the ceiling, with the cash flow statement showing the accrual drop rebuilding. - A close above 71.09 that holds, or an identified benign 9/18 cause under my definition.

What would make me more bearish: - Q3 FCF under $2.0B, or a second consecutive working-capital drain. - Operating margin under 30%, which would mean the Q3'25 and Q4'25 dips were seasonal, and my illustrative $58 (18x run-rate EPS) stays live. - A close below $65 on volume.

Still unknown: the earnings date, the 9/18 cause, the Q1 $2.85B item and the cash taxes on it, what drove the Q2 accrual drain, and sentiment, since the feeds were empty.

If Q3 clears a table this strict, I was too cautious. If it doesn't, the wait cost nothing.

Research Manager

Recommendation: Underweight

Rationale: The bear won this debate fairly clearly, and by the end the bull had given up most of the claims that would have supported buying now.

What the bull still had: the business is not in trouble. Revenue grew 13.4%, gross margin held at 51.9%, operating margin was 33.4%, interest coverage is about 24x, the share count is down about 2% and net debt is low. The stock is 37% below its April 16 close even though earnings kept growing. Neither side disputed this, and the bear said plainly the business is not broken.

Where the bull gave ground: (1) Valuation. The 20x EV/EBIT figure did not survive the cash view. The bull agreed the stock trades at about 28-30x cash earnings based on Q2, after the stock-based compensation adjustment, and both sides called that fair, not cheap. The bull dropped the line that the stock was priced for the cash test to fail. (2) Cash conversion. H1 free cash flow excluding the one-time Q1 item converted only 46-53% of operating income into cash, while passing the $2.66B Q3 bar needs about 62-65%. The bull agreed the bear's central Q3 estimate of $2.5-2.6B makes passing roughly a coin flip, leaning short. (3) Buybacks. H1 buybacks only look funded because of the Q1 windfall. Without that item, net debt is up about $1.7B from a year ago, not down. (4) The bull's own test applied to history. No quarter without the windfall clears every Intact condition, Q2'26 triggers two Broken conditions, and the bull accepted that an Intact Q3 is a minority outcome. (5) The chart. All three SuperTrend levels point down, ADX is 34.9 (a strong, new trend), OBV is at its low for the window, the 22% rebound has been almost fully given back, all three heavy-volume gaps were downward, and the 9/18 gap is still unexplained. (6) Entry plan. The bull withdrew buying a starter position before the Q3 print.

Why Underweight and not Hold: both sides now agree new money should not go in before the print, there is no margin of safety, the chart points down and the most likely Q3 result is Amber. Holding a full position adds gap risk with no discount to compensate, and there is still a plausible path to about $58 (18x run-rate EPS, -15%), which sits near the bull's own downside case.

Why not Sell: the bear never claimed the business is impaired. A 13% grower with a sound balance sheet that has already de-rated by half can recover quickly if Q3 cash conversion comes in clean.

What we don't know: the earnings date, the cause of the 9/18 gap, what the $2.85B Q1 item was and whether cash tax on it has been paid, what drove Q2's $1.25B drop in accrued expenses, and sentiment, news and macro, because those feeds came back empty. The thin data is one more reason to keep positions small until Q3 reports.

Strategic Actions: 1) New money: no position before Q3. Don't initiate at $67.85.

2) Existing holders: cut to about 50-60% of a standard position. Sell into strength in the $71-75 gap zone, mainly at or above about $72, which is the bull's own ceiling where even he wouldn't buy. If the stock hasn't bounced, make a smaller first cut before the print so that a 10% gap to about $61 is an acceptable loss on what's left.

3) Downside rule: if NFLX closes below $65 on heavy volume (breaking the July low), stop adding and cut the remaining position by about half unless the 9/18 cause has been identified. Size for gaps rather than relying on a stop, because gaps have been 5-10%.

4) Q3 decision table (the bull's final table with the bear's four edits). Any single Broken trigger makes the result Broken. - INTACT, which needs all of: reported FCF >= $2.66B; FCF before working-capital changes >= $2.5B; net debt at 9/30 <= $7.0B; operating margin >= 31%; opex growth <= 18% year over year; price no higher than about 30x SBC-adjusted cash earnings (about $72 now, recalculated with Q3 actuals). Action: move up toward a standard position in stages. Add one-third right away. Add the rest only on a close above $71.09 that holds, or once the 9/18 cause is identified, and only while price stays under the ceiling. - AMBER (neither Intact nor Broken): stay underweight. The one exception: FCF before working-capital changes >= $2.5B, content cash spend / amortization <= 1.10x, all other conditions pass, and no second working-capital drain above about $0.3B. In that case, add one-third. - BROKEN, triggered by any of: FCF < $2.0B; operating margin < 30%; opex growth > 20%; content ratio >= 1.15x for a second straight quarter. Action: exit any remaining position and revisit $58 (18x run-rate EPS) as the next valuation anchor. An identified 9/18 cause only counts if it is a named, public, company-specific event, addressed in the Q3 release or call, with a quantified effect that doesn't touch the FCF, margin or opex conditions. Anything vaguer doesn't count.

5) Don't average down blind. If a good print is followed by further selling and the 9/18 cause is still unexplained, don't add.

6) Before the print: confirm the earnings date, look for the 9/18 catalyst, and find out whether cash tax on the Q1 item has been paid. If not, it may hit Q3 or Q4 free cash flow.

7) Signals that would upgrade the view to Hold or Overweight: an Intact Q3 with the accrued-expense drop visibly rebuilding, or a close above $71.09 followed by the daily SuperTrend flipping above $74.86.

III. Trading Team Plan

Trader

Action: Sell

Reasoning: The research plan's Underweight maps to Sell: trim existing holders to about 50-60% of a standard position and add no new money before the Q3 print. The chart agrees. All three SuperTrend tiers are down, ADX is 34.9 and rising, price is below the 10 EMA, 50 SMA and 200 SMA, MACD is negative, and OBV is at its window low with no divergence. Valuation is only fair at about 28-30x cash earnings, Q3 free-cash-flow conversion is roughly a coin flip leaning short, and the earnings date and the cause of the 9/18 gap are unknown, so holding a full position carries gap risk with no discount. This is not a full exit because the business is sound (13% growth, 33% operating margin) and a clean Q3 could recover quickly. The daily TD-9, RSI of 32.45 and z-scores near -1.6 make a relief bounce plausible, so sell into strength in the 71-75 gap zone rather than at the lows.

Entry Price: 72.0

Stop Loss: 65.0

Position Sizing: Reduce an existing position to about 50-60% of a standard size. Make a smaller first cut before earnings if there is no bounce, so that a roughly 10% gap to about 61 is acceptable on what's left. Initiate nothing new. If NFLX closes below 65 on heavy volume, cut the remainder by about half. Size for gaps of 5-10% rather than relying on the stop.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: Neither of you has spoken yet, so I'll answer the objections I expect. My case is that trimming to 50-60% and selling into strength is the aggressive move here, not the timid one.

Start with what the tape says. ADX went from 9 to nearly 35 in about two weeks. All three SuperTrend tiers are down, price is under the 10 EMA, 50 SMA and 200 SMA, MACD is negative with a still-falling histogram, and OBV is at its window low with no divergence. Selling is confirmed by volume. That's a trend with momentum, and fading it ahead of a binary event is not boldness. It's donating edge to the market.

The neutral analyst will point to the oversold readings: daily TD-9, RSI at 32, z-scores around -1.6. I'd answer that RSI hasn't crossed 30, and in a trend with ADX near 35 it can stay depressed or go lower. None of the z-scores reach the 2-sigma mark. The weekly TD count is only at 4 and the monthly at 5, so the higher timeframes are early in their setups. A daily 9 against that backdrop is a bounce signal, not a bottom signal. That's why the plan sells into the 71-75 gap zone instead of dumping at 67.85. We use the neutral analyst's bounce as our exit liquidity.

The neutral analyst's best argument is that the stock is already down about 37% from the April high while revenue grew 13% and operating margin sits at 33%. That's fair, and I'll concede valuation isn't stretched. At roughly 26-27x normalized earnings at today's price, it's reasonable. But reasonable isn't a discount, and the drivers underneath are softening. Q2 free cash flow fell 33% year over year while net income grew 9%. Cash content spend is running about 1.15x amortization, up from about 1.03x. Operating expenses grew 17.7% against 13.4% revenue growth. Buybacks were about three times free cash flow, cash dropped $3.2B in a quarter, and current debt more than doubled to $2.5B. Trailing EPS is also flattered by that unexplained $2.8B Q1 item. A stock at fair value with weakening cash conversion and a downtrend is not one to hold at full size into a print.

The part that bothers me most is that three heavy-volume gaps have happened in this window: April 17, July 17 and September 18. We don't know what drove the last one, and our sentiment and news tools returned nothing useful. We also can't confirm the earnings date. When you can't see the catalyst and the tape keeps gapping, the right response is to cut size so a 10% gap to about 61 is survivable. That's why I size for the gap and don't lean on the 65 stop, which a gap would skip.

To the conservative analyst, who will say exit entirely: I disagree, and it isn't sentimentality. The business is sound, and the Q3'25 comparison is easy at a 28.2% operating margin. A clean print could recover quickly, and a full exit at the lows forfeits that. Hastings also hasn't sold since June, and recent insider selling is small. That's not bullish, but it isn't the earlier heavy distribution either. Holding 50-60% keeps meaningful upside while capping the damage from a gap. The remainder gets cut by roughly half if NFLX closes below 65 on heavy volume.

The upside of this plan is the cash it frees up. Capital that isn't stuck in a falling stock can be redeployed aggressively if the print is clean, or if price reclaims the 10 EMA at 71.09 and then the daily SuperTrend at 74.86. I'd flip quickly on that evidence. The plan costs us only the tail of a rebound, and it protects against a gap that could take 10% or more. I'll take that trade.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: I'll start with the hits you both landed, because they're fair. I overloaded 71.09. If a reclaim of the 10 EMA is where I'd start buying, I can't also be selling there. So a reclaim of 71.09 only means I stop selling, and the daily SuperTrend at 74.86 is where I'd redeploy. And a single limit at 72 shouldn't carry the whole plan. The plan as written already says to make a smaller first cut before earnings if there's no bounce, so the claim that it hinges on a fill skips that sentence. Still, I'll tighten it. Ladder the sales instead of using one price: a slice near 70, another into 71 to 72.5, and the rest toward the gap zone. I'll also take the neutral analyst's time backstop. If there's no bounce three or four sessions before the print, or the date lands inside a week, we go to 50-55% at the market. That removes the fill-risk objection without changing the thesis.

Now the conservative analyst. You say that if the oversold readings aren't extreme, there's more room to fall, so we should hold a quarter to a third or go flat. But ADX at 35 measures momentum. It tells you nothing about the sign of an earnings gap, and the next two weeks are dominated by that event. Going flat isn't the cautious option. It's a one-way bet that the print is bad or that the bounce isn't worth owning. You said that when you can't see the catalyst you can't put odds on the downside. The same ignorance applies to the upside.

The arithmetic is closer than you make it sound. Selling 70% at 67.85 and buying back at 71.09 to 74.86 costs 5 to 10% on that 70%, which is roughly 3.4 to 7.2 points of a standard position. Avoiding a repeat of the 10.6% April gap saves about 7.4 points. That's a wash, and the stock sits at a completed daily TD-9, RSI 32, 2.4% above the lower band and 0.25 above the July closing low. You'd be selling the most stretched price in the window, and my plan already covers the largest gap we've observed. Your trigger of a close below 67.60 is about an eighth of an ATR away. It's a sell order for tomorrow with a trigger label on it.

I'll concede that all three observed gaps were down. But the stock is already down 18% from the early-September high and 37% from April, so some of the bad news is priced. The July gap day closed 5% off its open, and the stock rallied 22% from there. A 22% rally from this same area is twice the biggest gap we've seen, even though it took six weeks.

On valuation, I agree it's no cushion. But the 26-27x normalized multiple sits on a trailing base that still includes two soft quarters, Q3'25 and Q4'25. On the last two clean quarters annualized, my rough estimate is more like 22x. The 3% free cash flow yield uses a base that includes a $1.3B working-capital drain that can partly reverse. No cushion is a reason not to add, not a reason to be flat. Hastings also stopped selling $33-45M a month after June, which removes a steady supply overhang. It isn't bullish, but it doesn't argue for dumping.

Now the neutral analyst, who spent most of the time agreeing with me. Your plan is the trader's plan plus a pre-emptive sale and a backstop. I'll take the backstop and decline the pre-emptive sale. You told the conservative analyst that selling at the lows of a three-day slide with a TD-9 is a mistake, then proposed selling a quarter at tomorrow's open. That's the same flaw at smaller size. A ladder gives you the same de-risking if a bounce shows up, and the time backstop covers you if it doesn't.

Your re-entry is also too timid. You criticized the conservative analyst for locking in a 5-10% cost, then proposed buying back only a third of what was sold after a clean print. If the print is clean against an easy 28.2% margin comparison, with 13% growth and a 33% operating margin, the whole point of freeing the cash is to buy it all back. After the print you know the catalyst's outcome. That's the best entry we get, and I'd redeploy fully.

On the stop, I'll take your closing trigger around 65.8 (one ATR) on heavy volume over my 65. Both of us accept that a gap will skip it.

So my position is to hold about half through the print. Ladder the sales into any strength. Use the time backstop if no bounce comes. Cut again on a heavy-volume close near 65.8. After the print, buy back aggressively if it's clean or if we close above 74.86. That keeps real exposure to the upside, survives the gap we've already seen, and doesn't turn a growing, high-margin business into a short-term short at a TD-9.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Let me start with what you've both done to my plan, because some of it lands.

Conservative, you're right about the ladder. Limits at 70 and 72 only fill in the scenario where I was already fine, and in the scenario that hurts they fill nothing. Neutral's clock point makes it worse: if the print is eight to ten sessions out, the ladder gets maybe five sessions to work before the backstop hits at market. A plan shouldn't depend on a fill, and I've been guilty of that. Neutral is also right that I was being inconsistent. I called the TD-9 a bounce signal, and a bounce signal isn't a reason to sit at full size through the part of the calendar where we know least. The September 18 gap on 114 million shares had no identified cause, so event risk doesn't wait for earnings. So I'm moving. I'll take a first cut of about a fifth over the next two sessions, selling any strength rather than hitting the open. The ladder at 70 to 72.5 handles the next tranche, with the date-based backstop to get to about 50% before the print.

I'm also dropping the 22x. Neutral is right that I annualized the two best quarters, and one of them needs my own estimate of the Q1 item. On roughly $2.5 to $2.6 of normalized EPS, this is a 26 to 27x stock. That's fair, not cheap, and I'll stop arguing otherwise.

Now the part I won't give up, which is the third versus the half. Go through the arithmetic honestly. The gap between a third and a half is about 17 points of a standard position. On a 10% gap down that's about 1.7 points saved, and on a 10% pop it's about 1.7 points missed. So we're arguing over less than two points of position in either direction, and you can't pick the winner by deciding which scenario is likelier, because we have no earnings date, no sentiment data, no macro readings and no news. Conservative, you keep treating the absence of information as bearish evidence. It isn't. The tools came back empty, and empty is symmetric. The trend tells us about drift, but it doesn't tell us the sign of an earnings gap. The two earnings-style gaps we have went opposite ways in practice. April kept sliding for two months, and July opened at 65.48, closed at 68.95 and then ran about 22%.

Your July comparison is fair in one respect. That low came on 142 million shares and today's volume was 41.6 million, so there's no capitulation. That tells me not to add, and it's why I'm selling half. It doesn't tell me to sell two-thirds.

The bigger problem with your plan is the one Neutral spotted. Carry a third into the print, cut half of it on a close below 65.8, and you're at roughly 15 to 17% exposure. Then you only rebuy once the stock holds its reaction and later closes above 74.86, about 10% above today. If the print is clean and the stock gaps through that level, you chase it. If it never triggers, you never get long again. You'd have turned a trade into a permanent underweight in a business growing 13% at a 33% operating margin, because of a rule written before we knew anything.

Neutral, I'll take your point that a clean number and a clean reaction differ, and that I overreached on redeploying everything on day one. But I won't wait for 74.86 either. I'd rebuy about half of what I sold if the stock holds through the session after the print. The rest comes back over the next few sessions if there's no failure, or on a close above 74.86 if it's slower. Having the cash at that moment is the point of this whole exercise, and it should be used.

I also agree with your caveat on a post-gap-down print. If it opens in the low 60s, I'm not dumping the remainder out of rule-following. At about 24x normalized, the question is whether anything fundamental changed. The 65.8 trigger is for pre-print breakdowns, not a reflex after the event resolves.

So that's the plan. Check the earnings date first, because it sets the clock. Sell about a fifth into strength over the next two sessions. Ladder toward 50% at 70 to 72.5, with a market backstop about five sessions before the print or immediately if the date is inside a week. Carry about half through the print, which on a 10% gap to 61 costs about five points and keeps real participation if the number is good. Cut a third to half of the remainder on a heavy-volume close below 65.8, knowing a gap skips it. Rebuy in stages after the print. That's a Sell that sizes for the gap and still lets us own the rebound.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Let me take your two best points first and then say where I still disagree.

Neutral, you're right that a fifth is thin. I said event risk doesn't wait for earnings, and the 9/18 gap on 114 million shares proved it. A fifth, then a ladder that may not fill, leaves me near full size through the stretch where we know the least. I'll go to a quarter over the next two sessions, sold into whatever strength shows up rather than hit at the open. The cost in upside is trivial, and it's consistent with what I've already conceded.

Conservative, your question about where the half I keep goes if we rally into 74.86 and 75.60 is the best one left, and my plan had no answer. Neutral's rule is the answer, and I'm taking it. If the retained sleeve rallies into 74 to 76 and stalls before the print, the bounce has paid us and I shave to 40 to 45%. A daily close above 74.86 flips the daily SuperTrend, so I stop trimming and start thinking about adding. That gives the kept position an exit on both sides: the 65.8 heavy-volume close below, and the stall at resistance above. The July round trip you cited, from 67.60 up to 82.73 and back to 67.85, only hurts a holder with no rules. With these rules, holding half through a bounce is a trade with an exit.

Now the sizing. Your drift argument stacks a 10% gap on 7% of follow-through and gets a 2.8-point difference between half and a third. But you've already agreed the post-print hold should rest on cash conversion, the content spend ratio and the buyback pace. That review is the drift protection. April's follow-through was a two-month grind with plenty of sessions to act on evidence, not a second gap. Also, April started from a much richer place. On today's normalized EPS of about $2.5 to $2.6, 97 is high 30s and 107 is low 40s. A gap to 61 lands near 24x. A drift scenario that starts from 24x on a business growing 13% at a 33% operating margin is not the same animal as one that starts from 38x. Size covers the gap, review covers the drift, and the gap difference between a third and 40 to 45% is a point or so.

On fundamentals, your FCF comparison is steeper than it looks. Q2 free cash flow was $1.53B after a $1.3B working-capital drain. Add that back and it's about $2.8B, already above Q3'25's $2.66B. You don't need the drain to reverse for the comparison to be manageable, you only need it not to repeat. On margins, Q3'25 was 28.2%. If Q3'26 prints anywhere near the 32 to 33% of the last two quarters, that's roughly four or five points of year-over-year expansion in the headline. The market knows the comp is easy, but that doesn't make a surprise impossible, and it's why I want real exposure on the other side of the print.

Here's what I think the third-versus-40% choice comes down to. A carry of a third, cut by half on a 65.8 close, leaves 15 to 17% of a position. That's a bet on being right about the downside, and it only works if the print goes badly. If the print is clean, you've paid the insurance premium and own too little to use what you learned. I'd rather size for survival and still be able to get paid, because the reason to free up cash is to redeploy it where the information is best, which is right after the print.

So my plan is this. Check the earnings date first. Sell about a quarter over the next two sessions into strength. Ladder the second tranche toward 50% at 70 to 72.5, with a market backstop about five sessions before the print, or immediately if the date is inside a week. If the bounce reaches 74 to 76 and stalls, shave to 40 to 45%. A close above 74.86 stops the trimming. A heavy-volume close below roughly 65.8 cuts a third to half of what's left. If the print gaps down, I don't dump the remainder reflexively. I hold or cut based on free cash flow, the content ratio and the buyback pace. After the print I rebuy about half of what I sold if the stock holds its reaction through the next session, and the rest on evidence. I'd rather own a good business through a print with a plan than watch from 15% and call it prudence.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Most of this has converged, so I'll say where I've moved and where I haven't.

Conservative's best point is that the lower carry only shows up in the path where we didn't need it. If the stock grinds lower, my 70 to 72.5 limits never fill and the backstop is the only thing that gets me down. I should have said that plainly instead of quoting a 40 to 45% carry. I'm taking Neutral's fix: the market backstop targets 45%, whether or not the limits fill, and 40% if the date is inside a week. The shave at 74 to 76 is a bonus, not something the plan leans on. Neutral is also right that my "watching from 15%" line is stale, since Conservative now cuts only a third of the remainder on the 65.8 close. I'm retiring it.

I still don't accept that the sleeve only has an exit in the paths that didn't hurt. A gap skips 65.8, but a grind doesn't. The April follow-through was a grind, the slide into the July low was a grind, and the stretch after 9/18 has been a grind. A heavy-volume close under 65.8 is the rule built for those paths. Only the gap itself is unprotected, and that's what size is for.

Conservative also says the review after a gap happens while the stock is down ten percent, so size is the only hard protection. That's true, and it's why I'm carrying about 45% and not the 50 to 60% in the trader's plan. But the size difference is small. At 45% versus a third, a 10% gap costs about 4.5 points versus 3.3. Add 7% of drift and it's about 7.7 versus 5.6. On the other side, a July-style 22% run is worth about 9.9 versus 7.3, and a 10% bounce is worth about 1.2 either way. The stacked-bad case costs a third about 2.1 points less, and the full-run case costs it about 2.6 more. Those roughly cancel, and with no earnings date, no usable sentiment, and no macro readings, nothing here tells us which tail is likelier. The one macro headline we have is Gundlach's hollow-tree warning, and the Accenture-led tech rally points the other way.

There's also a cost nobody has priced. If the print is clean and the stock gaps up 8 to 10%, the smaller carry misses the gap, and the rebuy of half of what was sold happens at 73 or higher, above where we sold. That's the real premium on over-insuring. After the rebuy, a third-carry plan ends near 67% exposure and a 45% carry ends near 72%. The two plans end up a few points apart, and the only thing the lower carry really buys is lower variance in the bad tail.

On valuation I'm done arguing for a cushion. At 61 the market cap is roughly $254B, against normalized FCF of about $8.3B, a yield near 3.3%. That's not a floor, and a 24x multiple rests on our own estimate of the Q1 item. I'd add that the $8.3B still carries Q2's $1.3B working-capital drain, so it's probably a bit light. That makes the stock fair and not broken, and it argues against adding, not against holding half.

Neutral's last point matters more than the carry debate. We're arguing over about a dozen points of position, which is about a point of P&L on a 10% move. The data can't resolve that, so the choice should rest on whether each rule can be executed. A third requires selling two-thirds of the position into a completed daily TD-9, RSI at 32, and a price 0.25 above the July closing low. Staggering helps the average, but that's still the weakest-looking part of the plan. The plan that works in every path is Neutral's.

Our data stops at the October 1 close, and today is October 2, so check the live price and the earnings date before anything else. Then sell about a quarter over the next two sessions, roughly half of it without waiting for a bounce and the rest into any strength toward 69 to 70. Put limits at 71 to 72.5. Use a market backstop to reach 45% about five sessions before the print, or immediately if the date is inside a week. Carry about 45% through the print, or 40% if the date is close. Cut a third of what's left on a heavy-volume close below roughly 65.8, and stop trimming above a daily close over 74.86. After the print, rebuy about half of what was sold if the stock holds its reaction through the next full session, and judge the rest on free cash flow against Q3'25's $2.66B, the content cash-to-amortization ratio, and the buyback pace.

That sells into weakness without relying on a fill. It sizes for the gap we've already seen, and it keeps enough exposure that a good print isn't something we only watch.

FINAL TRANSACTION PROPOSAL: SELL

Conservative Analyst

Conservative Analyst: I agree with the aggressive analyst on more than he might expect, and that's why I think the plan doesn't go far enough.

He leans on the trend: ADX from 9 to almost 35, all three SuperTrend tiers down, OBV at its window low with no divergence. Then he says the oversold readings are weak because RSI hasn't crossed 30 and no z-score has hit 2. I accept that, but it cuts against holding more than half. If those readings aren't extreme yet, there's more room to fall, and the technical report itself calls continuation the higher-probability case. A trend argument that ends with keeping 50 to 60 percent of the exposure isn't committed to its own logic.

The plan also contradicts itself on the bounce. He says RSI can stay depressed in a trend this strong, yet the plan depends on a rally into the 71 to 75 zone to execute the sale. That's 5 to 10 percent above today's close, and it starts at the 10 EMA, the very level he says he'd flip to buying on if price reclaims it. So the plan sells where he'd turn buyer, and it only works if a bounce arrives that his own trend reading says may not. A risk plan shouldn't hinge on a limit order filling. The first cut should happen now, not on a rally that may not come.

His gap sizing also isn't conservative. He sizes so a 10% gap to about 61 is survivable, but the April 17 gap was already about 10.6%, from a 107.79 close to a 96.37 open. That's the observed size, not the tail. The September 18 gap was about 5%, and July 17 was heavy-volume too. The first two came in mid-April and mid-July, which points to mid-October, though no tool confirms the date. And we can't identify the cause of the September 18 drop. When you can't see the catalyst, you can't put odds on the downside, so the answer is a bigger haircut, not a size that merely survives a repeat of the last gap. His closing-basis cut below 65 also fires only after the damage, and it sells half of what's left, so a quarter or more of the position is still exposed.

On fundamentals, he concedes weakening cash conversion, buybacks at about three times free cash flow, cash down $3.2B, current debt more than doubling and opex outgrowing revenue, then calls 26 to 27 times normalized earnings reasonable. That normalization is itself an estimate, because no tool could explain the $2.8B Q1 item. By my rough arithmetic, 4.16B shares at 67.85 is about $282B of market cap. Against normalized free cash flow near $8.3B, that's a yield around 3 percent, on a number that's falling. That's not a cushion for a stock that's gapped down three times. The Q2 buyback was also partly funded from Q1's cash, so I wouldn't count on that bid repeating at the same pace.

He also points to Hastings not selling since June and calls the easy Q3'25 comparison a reason to hold. Absence of selling isn't buying, and there have been no open-market insider purchases at all. The market knows the comparison is easy, and the stock fell 18% from its early-September high anyway.

I expect the neutral analyst to argue for holding closer to full size because of the TD-9, RSI and fair valuation. I'd say that a daily setup against weekly and monthly counts of only 4 and 5 is a bounce signal at best, and a fair multiple is no protection from a gap.

My adjustment: first, check the earnings date today, since it governs everything else. Second, cut now, not at 72. Take the position to roughly a quarter to a third of standard size, and go flat before the print if the date is confirmed inside the next couple of weeks. Third, make a close below 67.60, only 0.25 below today's close, the trigger for the next cut, and use 65 to clear what's left. Fourth, re-buy only after the print or after a reclaim of 71.09 and then 74.86. He says the plan costs us only the tail of a rebound. Missing the first leg of a recovery is a far smaller cost than owning most of a position through a gap we can't see coming.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: I'll start with what you each got right. Neutral is correct that a trigger 0.25 under the close is noise when ATR is 2.04, so I'm dropping it. I'll use a close below about 65.8, one ATR down and just under the 66.27 band, on heavy volume. Aggressive is correct that the trader's plan does include a pre-earnings cut if there's no bounce, so I overstated the fill dependence. And you're both right that insurance isn't free and that our ignorance about direction is symmetric. But symmetric ignorance doesn't call for symmetric sizing when the losses are the ones I can't exit.

Aggressive, your ladder has an adverse-selection problem. Limits at 70, 71-72.5 and the gap zone fill only if the stock rallies, which is the scenario where we were fine anyway. In the scenario that hurts, where the trend keeps running with ADX at 35, nothing fills, and the time backstop sells at market several sessions before the print at lower prices. So the plan turns "sell at 67.85" into "sell at 67.85 minus whatever the trend takes in the meantime." The backstop is also tied to a print date nobody has confirmed. The September 18 gap came on 114M shares with no known cause and apparently nothing to do with earnings. Event risk isn't confined to the print, and your plan holds close to full size through the interim.

Your arithmetic also compares two different states of the world. The 3.4 to 7.2 points of re-buy cost only occur if the stock rallies, and the 7.4 points of saved gap loss only occur if it gaps. Calling that a wash assumes 50/50 odds. The trend evidence points down, and all three observed gaps were down, which you conceded. The 22% rally isn't a banked reward either. The July 20 close was 67.60 and today's is 67.85, so anyone who held through that round trip earned nothing and sat through an 18% drawdown.

On valuation, your 22x annualizes the two best quarters and treats Q3'25 and Q4'25 as unclean. The fundamentals report says it can't attribute those margin dips, so we don't know they won't recur. Meanwhile opex is growing 17.7% against 13.4% revenue, FCF fell 33%, and cash content spend is running 1.15x amortization. The working-capital drain may reverse, but that ratio won't on its own. "Some of it is priced in" needs a cause, and we have none. The stock fell 37% while revenue grew 13%, and the report itself flags that this could be a specific issue outside the statements. Hastings stopping in June is also unexplained. It could be a plan expiry, and executives have sold into the high 70s and bought nothing.

Neutral, the July comparison is weaker than it looks. That low came on the heaviest volume in the window, about 142M shares, and it closed 5% off the 65.48 open. Today was 41.6M, opened at 69.41 and closed within six cents of the low. That's a weak close without capitulation, and OBV is at its window low. On your sizing math, the gap protection is worth 2.5 points. But the extra 25% of exposure earns 2.5 to 3.75 points only if the stock rallies 10-15%, and 15% means roughly 78, through the daily SuperTrend at 74.86 and the 50 SMA at 75.60. A bounce that stalls at resistance is more like 5-10%, which earns 1.25 to 2.5 points. That's a loss of the trade-off you called close. Compression from 29x to 26x isn't a cushion either. The price fell, but the earnings base is still uncertain.

You also propose selling a quarter at tomorrow's open, so we differ mainly on size. If the TD-9 worries you, I'd stagger the cut across two or three sessions, not wait for 72.

My adjusted plan: 1. Check the earnings date today. 2. Cut to about a third of standard size, staggered over two or three sessions. 3. Cut half of what's left on a heavy-volume close below 65.8. 4. Carry no more than a third through the print. 5. Rebuy in stages. Add a third after the print only if the stock holds its post-print reaction, and the rest on a close above 74.86. A clean number doesn't guarantee a clean reaction.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: Let me start with where Aggressive is right. Empty tools aren't bearish evidence, so I'll stop treating the missing earnings date and sentiment data as if they pointed down. I'll also drop 74.86 as my only re-entry trigger. Neutral is right that a rule requiring a close about 10% above today can leave us underweight a business growing 13% at a 33% operating margin. After the print I'd rebuy about half of what I sold if the stock holds its reaction for a full session. The rest would depend on the quarter's evidence: free cash flow against Q3'25's 2.66B, the content cash-to-amortization ratio, and the buyback pace. A price level alone shouldn't decide it.

Now the sizing math. Aggressive says a third versus a half is 1.7 points of position either way. That's true only if the downside stops at the gap. April's gap was the first installment. The stock closed at 97.31 the day after and was at 70.90 by late June, another 27% down. Suppose a 10% gap to 61 is followed by just a quarter of April's follow-through, about 7%. That's roughly 17% on the stock, which costs 8.5 points at half size and 5.7 at a third. The difference is 2.8 points, not 1.7. On the other side, a bounce runs into the 74.86 SuperTrend and the 50 SMA at 75.60, about 10% up, so the extra exposure earns at most about 1.7. The payoffs aren't symmetric once you include drift after the gap.

You're also both now saying not to cut the remainder reflexively if the print gaps down. I understand the reasoning, and I'll accept it with one condition. The hold has to rest on the quarter's numbers, not on a 24x multiple that depends on my estimate of a $2.8B Q1 item. But that means the 65.8 trigger only protects us before the print. After a gap, the only protection is the size we carried in. That's the case for a smaller carry, and it's the part of the plan I don't think gets enough weight.

Aggressive, you said the two earnings-style gaps went opposite ways. The gap direction didn't. April opened 10.6% below the prior close, and July opened at 65.48, both down. What differed was the aftermath. The July rebound was real, 22% in six weeks, but it went from 67.60 to 82.73 and back to 67.85. A bounce there was a trade. Holding half for it only paid if you sold near the top, and your plan has a ladder for selling on the way up but no exit rule for the half you keep. If we rally into 74.86 and 75.60, where does that half go?

On fundamentals, the easy comparison is the 28.2% Q3'25 operating margin, and the market knows it's easy. The free cash flow comparison is not easy. Q3'25 was 2.66B and Q2'26 was 1.53B, so matching it takes about a 74% sequential jump. Opex is growing 17.7% against 13.4% revenue. The Q2 buyback was about three times free cash flow, drew cash down by 3.2B, and sits next to 2.5B of current debt. I wouldn't count on that bid repeating at the same pace.

Neutral, I think your July point is overstated. The half-position holder captured about 11 points of the run and then took about 9 points of the 18% drawdown, so from the 67.60 close to today they're roughly flat unless they sold near the top. Your own point that a trend signal against full size doesn't automatically work against half size is fair. But we know a trend with ADX at 35 will cost us over the next eight to ten sessions, before the print even matters. And a third in isn't a bet on direction. It's sizing to what I can afford to be wrong about when I can't see the catalyst.

So I'm converging on the shape you've both described, with a lower carry. Check the earnings date today. Cut to about two-thirds over the next two sessions, selling strength where it appears. Be down to about a third by the time we're a few sessions from the print. If the date is more than ten sessions out and we close back above the 71.09 10 EMA, I'd allow up to 40%. Cut again on a heavy-volume close below about 65.8. After the print, judge the hold on cash conversion and rebuy in stages on evidence. That keeps real participation in a good print while leaving us able to survive another drop like April's.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: Let me start with where you've moved me. Neutral, "will cost us" was too strong. ADX says the trend is real, and the technical report calls continuation the higher-probability path, not a certain one. I'll take that back. You're also right about the 15 to 17 percent floor, so I'm changing the rule. On a heavy-volume close below 65.8 I cut a third of what's left, not half, which leaves me around 22 to 25 percent. Aggressive, I accept your free cash flow arithmetic. Add back the $1.3B working-capital drain and Q2 is about $2.8B, so matching Q3'25's $2.66B isn't a 74% leap. I'll stop using that number.

Now the parts I don't accept. First, I think you've both walked past a problem with your carry numbers. The 40 to 45 percent figure only appears if the stock bounces into 74 to 76 and stalls, because that's the only trigger that takes you below 50. In the scenario that hurts, the stock keeps sliding, your 70 to 72.5 limits never fill, and the market backstop five sessions before the print takes you to 50. So what you actually carry into a downside gap is half, the bottom of the trader's original 50 to 60 range. The lower carry shows up only in the path where we didn't need it. A third holds in both paths.

Second, "size covers the gap, review covers the drift" is a good framework, but the review happens after the information is in the price. The numbers and the reaction arrive together, and you've both said you won't cut reflexively after a gap. That's reasonable, but it means the only hard protection after a gap is the size we walked in with. The review is a judgment call made while the stock is down ten percent. April's follow-through wasn't a second gap, but it was still about 27 percent of drift, from 97.31 to 70.90. A review can only act on the sessions after the gap, not on the gap itself.

Aggressive, on valuation, 24x at 61 rests on normalized EPS of $2.5 to $2.6. That comes from backing out a $2.8B Q1 item that nobody could identify. At 61 the market cap is about $254B against normalized free cash flow of about $8.3B, a yield near 3.3 percent on a number that's trending down. A lower multiple than April isn't a floor. The stock already compressed from 29 or 30x to 26 or 27x and kept falling. On margins, 32 to 33 percent against 28.2 is the path everyone has modeled. The surprise would have to be bigger than the comp, with opex growing 17.7 percent against 13.4 percent revenue and cash content spend at 1.15x amortization.

Your sleeve rules are better than nothing, but look at what each exit does. The upside shave needs a 9 to 12 percent rally, which is the scenario where we were already fine. The downside exit is a close below 65.8, which a gap skips. So the sleeve has a real exit only in the paths that didn't hurt.

Here is where I think the disagreement actually sits. It's a third versus 40 to 45 percent, roughly a point of position either way on a 10 percent move. Neutral's 3.7 points of missed upside assumed a 22 percent run, but in that path we both have rebuy rules that trigger through 74.86, so the cut side doesn't miss the whole move. When the expected payoffs are that close, and the bad tail is the one we can't exit by rule, a mandate built on preservation takes the lower variance.

My plan is this:

1. Check the earnings date today.
2. Cut to about a third over the next two or three sessions. Use strength if it shows, but don't make the first half of the cut depend on it.
3. Allow up to 40 percent only if we close back above the 71.09 10 EMA with the print more than ten sessions away.
4. On a heavy-volume close below about 65.8, cut a third of what's left.
5. After the print, rebuy about half of what was sold if the stock holds its reaction through the next full session. Judge the rest on free cash flow, the content ratio and the buyback pace, not on a price level.

I'm not arguing for being flat or for fifteen percent. I'm arguing for a size I can be wrong at without needing a stop that a gap would skip.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: Aggressive, I'll start with what I'll give you. The rebuy premium is real. If the print is clean and the stock gaps up eight to ten percent, a smaller carry misses the gap and then buys half of what it sold back above where it sold. That's about two points of position, and I won't pretend otherwise. I'll also stop leaning on the macro headlines. Gundlach is one investor's opinion, and the Accenture rally is an IT-services story, not a Netflix one. I weight neither, which is your symmetry point, and I accept it on that side.

You're also right on valuation. Normalized free cash flow of about $8.3B still carries Q2's $1.3B working-capital drain. Add it back and you get roughly $9.6B, a yield near 3.4% on today's market cap of about $282B. I'll use that figure. It's still not a cushion while cash content spend runs 1.15x amortization, but it's fairer than the 3% I quoted.

Neutral, you said we should choose on whether each rule can be executed, not on who's likelier to be right about direction. I'll take that test, because the plan we've converged on fails it in one place, and I wrote that rule myself. We all say to cut a third of what's left on a heavy-volume close below 65.8. The recent down days have run about 36 and 42 million shares, going by the OBV changes on 9/30 and 10/1. The gap days ran 82 to 142 million. If "heavy" means anything like gap-day volume, the rule fires only on gap-like days, and a gap skips it. A quiet grind through 66 never triggers it, and that's the path you both say the rule is built for. So I'm dropping the volume filter. A close below 65.8 is already below the lower Bollinger band and about one ATR under today's close, which is enough on its own. A rule meant to cover grinds has to fire on a grind day.

The second executability problem is the backstop. It's keyed to five sessions before a print nobody has confirmed. We all say to check the date first, but the plan needs a default if the date can't be pinned down. If it isn't confirmed by Monday's close, I'd assume mid-October, treat the print as inside two weeks, and run the backstop on the calendar. A plan that waits on information we may not get isn't a plan.

There's also a gap in what we know. We don't know the caller's holdings. Everything here is a percent of a standard position, so the carry only means something if that position was sized sensibly to begin with. If the person is flat, the plan is simply not to initiate before the print. If NFLX is already an oversized weight, 45% of it is still a large exposure into an event we can't see. A lower carry holds up better across what we can't observe, and a higher carry is only right if the starting size was right.

On the carry itself, I'll move. I'll set a flat 40% carry instead of a third with a conditional exception, and 35% if the date is inside a week. That also fixes the path-dependence you found, since the downside carry is the same in every path. It leaves us about five points of position apart, and nobody can defend a winner at that distance on this data. I still wouldn't carry 45 to 50. After a gap, the only hard protection is the size we walked in with. Your review of cash conversion and buyback pace is good, but it's a judgment call made while the stock is down ten percent.

My plan is this. Check the date and the live price first, since our data stops at the October 1 close. Sell down to about three-quarters over the next two sessions, half of that without waiting for strength and the rest into any bounce toward 69 to 70. Put limits at 71 to 72.5 for the next tranche, and reach 40% by the calendar backstop, or 35% if the print is inside a week. Cut a third of what's left on any close below 65.8, with no volume condition. Stop trimming on a daily close above 74.86. After the print, rebuy about half of what was sold if the stock holds its reaction through the next full session, and judge the rest on free cash flow against Q3'25, the content cash-to-amortization ratio, and the buyback pace.

FINAL TRANSACTION PROPOSAL: SELL

Neutral Analyst

Neutral Analyst: Both of you have found real flaws in the other's plan, but each of you then fixes the flaw with a move that has its own flaw.

Aggressive first. The conservative analyst caught your biggest weakness. Your plan says the trend is strong enough that RSI can stay depressed, but it also needs a rally into 71-75 for the sale to execute. Those two statements pull against each other. If ADX at 35 means the trend persists, the bounce may never come, and you end up holding 100% of the position into a print you can't see. A limit order isn't a risk plan. Your fallback is also late. A close below 65 only cuts half of what's left, so after a gap to 61 you'd still hold roughly a quarter to 30% of the original position at the lows. And treating 71.09 as the place to sell and also the place to flip to buying means your exit zone starts exactly where your own re-entry signal sits. I'd keep the 71-75 zone for the second tranche but not rely on it for the first.

Conservative, I think you overcorrect in three places. First, your trigger of a close below 67.60 is 0.25 under today's close, and ATR is 2.04. That's about an eighth of one day's normal range. It would fire on noise, so it can't separate a real breakdown from a routine wiggle. Second, you want to take the position to a quarter or a third right here. That's selling at the lows of a three-day slide, with a daily TD-9 completed, RSI at 32, and every z-score tier near -1.5 to -1.6. None of those is a buy signal, as you both agree. But this is also the same area where the stock bottomed in July. It closed at 67.60 on July 20 and rallied about 22% to the low 80s. Third, the July 17 gap itself opened at 65.48 and closed at 68.95, so the last gap that plausibly came from earnings was bought. April's gap kept sliding for two months. The two prior earnings-style gaps went opposite ways, which says the outcome is genuinely two-sided.

Your re-entry rule also locks in a cost. You sell at 67.85 and don't buy back until 71.09 or 74.86. If the bounce arrives, you've paid 5-10% for insurance on most of the position. That can be worth it, but it's not free.

On valuation, your 3% normalized free cash flow yield is fair as a statement that there's no big cushion. But the same math shows the stock has compressed from about 29-30x normalized earnings when insiders were selling at $76 to about 26-27x now. Q2 free cash flow was also depressed by a $1.3B working capital drain from accrued expenses, which can partly reverse. I wouldn't call that cheap, and I agree with both of you that it isn't a discount. But it's no longer the expensive setup that justified a heavy underweight.

On sizing, the numbers are closer than either of you suggests. A 10% gap down costs 5.5% of a standard position at 55% exposure and 3% at 30%. A 10-15% relief rally earns the extra 25% of exposure 2.5 to 3.75 points. Without a confirmed date, a catalyst, or any usable sentiment data, those two payoffs are close enough that the middle is the sensible place to be. The Hastings point is a wash too. The absence of selling since June isn't buying, and it isn't distribution either.

So I'd keep the Sell but run it as a staged trim rather than a single order.

First, check the earnings date today, because everything else depends on it. You both agree on that.

Second, start trimming now, not at 72. Sell roughly a quarter of the position at the next open or on any intraday strength, taking exposure to about 75%. That deals with the conservative analyst's concern that the bounce might not come, without selling the whole thing into the 67.60 area.

Third, make the next tranche a limit into the 71-72 zone, which is the aggressive analyst's idea, bringing exposure to about 50-55%. Add a time backstop. If there's no bounce by three or four sessions before the print, or if the date turns out to be inside a week, trim to that 50-55% level anyway at the market.

Fourth, don't go flat into the print. Hold about half. A gap to 61 on that is a loss I can live with, and a clean print with an easy 28.2% margin comparison still gets meaningful participation.

Fifth, replace the 0.25 trigger with something that sits outside daily noise. A close below the 66.27 lower band, or one ATR below at about 65.8, on heavy volume, cuts another third to half of what's left. That's the 65 area the trader already named, but on a closing basis, and it accepts that a gap will skip it.

Sixth, for re-entry, I wouldn't flip on the 10 EMA at 71.09. In a downtrend with ADX near 35, that's a stabilization sign and nothing more. Add back a third of what was sold after a clean print, or after a daily close above the 74.86 SuperTrend. Reclaiming 71.09 just means we stop selling.

That gives the aggressive analyst some upside and the conservative analyst a plan that doesn't depend on a fill, and both are still protected against the gap neither of us can see.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: Both of you have spent most of this debate fixing each other's plans, and by now you're closer than you sound. You both sell, both cut again on a close near 65.8, both want the earnings date checked first, and both want a staged re-entry. The real disagreement is how much you carry through the print (a third or half) and whether the first cut happens now or only if a bounce fails to show up. I think each of you is right about the other's weakest point, so let me press on that.

Aggressive, you took the time backstop, but notice what it does to your ladder. If mid-October is the usual slot, the print is only eight to ten sessions away. A ladder at 70, 71-72.5 and the gap zone, plus a market-order backstop three or four sessions before the print, leaves a very short window for the ladder to work. In the scenario where the trend keeps running, which ADX at 35 says is the live one, nothing fills for five or six sessions, and then you sell half at market at lower prices. The conservative analyst is right that this turns "sell at 67.85" into "sell at 67.85 minus whatever the trend takes." You also decline a small pre-emptive sale because of the TD-9, but the TD-9 is a daily signal sitting against weekly and monthly counts of 4 and 5. You said yourself it's a bounce signal, not a bottom signal. A bounce signal isn't a reason to hold full size for a week. The September 18 gap came on 114M shares with no known cause, and nothing says the next surprise waits for earnings. Your own plan holds nearly full size through the part of the calendar where we know the least.

Your valuation case is also generous. The 22x comes from annualizing the two best recent quarters, and one of those, Q1, needs my own estimate of the one-time gain to normalize. On the fundamentals report's normalized EPS of about $2.5-2.6, the stock is closer to 26x. I'd call it fair, not cheap, and that's the same conclusion you reached. Finally, buying back everything the moment the print is clean ignores that a clean number and a clean reaction are different things. After the April gap the stock kept sliding for two months, and a gap up on good numbers means you re-buy at a higher price. Redeploying in full on day one means you've paid for the insurance and then declined to use what it taught you.

Conservative, you've earned the point on staggering and on interim event risk, and I'm taking both. But your plan has its own problems. Carrying a third through the print and then cutting half of what's left on a 65.8 close takes you to roughly 15-17% exposure. Your re-entry then needs the stock to hold its post-print reaction and later close above 74.86, which is about 10% above today's close. That's a structural lock-in of the cost. If the print is clean, the stock may gap through 74.86 and you rebuy higher, or you never rebuy because the rule never triggers. The July episode shows the other side of your argument. You noted that someone who held from the July 20 close to today earned nothing and sat through an 18% drawdown. True, but someone who held a half position through that period captured a good part of the 22% run to the low 80s and then could have trimmed. A trend signal that works against full size doesn't automatically work against a half position.

Your sizing math also cuts both ways. You say the extra 25% of exposure earns only 1.25 to 2.5 points on a 5-10% bounce. But the gap protection it costs is also at most 2.5 points on a 10% gap, and only 1.25 on a 5% gap, which is what September 18 was. At the sizes in play, the gap-saved and bounce-missed numbers are about the same in magnitude, so the decision shouldn't ride on whichever one we've decided is likelier. We don't know the direction of the print, and the sentiment and news tools returned nothing. Trend momentum says something about drift, not about the sign of an earnings gap. So the plan should be robust to being wrong in either direction, and a third in is a bet that the downside is the likelier one, while 55% is a bet that the bounce is.

So here's where I'd land. First, check the earnings date today, since it sets the clock for everything else. Second, make the first cut now but not at one price: sell about a quarter of the position over tomorrow and Monday, using any intraday strength toward 69-70, and don't dump it all at the open. That answers the aggressive analyst's point about selling a TD-9 low, because staggering and selling strength gives you a better average than a single market order, and it answers the conservative analyst's point that the first cut can't depend on a bounce arriving. Third, take the second cut, down to roughly 50%, with a limit in the 71-72 area, but give it a date-based backstop. If the print is within a week or no bounce has come with about five sessions to go, trim at market. Fourth, carry about 45-50% through the print, toward 40% if the date is inside a week and nearer 50% if it's further out. A 10% gap to 61 costs about 4.5-5 points of a standard position at that size, which I can live with, and a clean print still gives real participation.

Fifth, use a closing break below about 65.8 on heavy volume as the trigger to cut another third to half of what's left, with the understanding that a gap skips it. I'd add one caveat the two of you haven't discussed. If the print gaps us down to the low 60s, don't automatically dump the remainder out of rule-following. At that point the stock would be around 24x normalized with the daily, weekly and monthly setups more stretched, and the better question is whether anything fundamental changed. The close-below-65.8 rule is for pre-print breakdowns, not a reflex after the event resolves.

Sixth, re-enter in two steps. After the print, rebuy about half of what was sold if the stock holds its reaction through the following session. Buy the rest on a close above 74.86, or on the next quarter's evidence if the print was bad. That's a compromise between full redeployment on day one and a third only.

Finally, one change to the trader's numbers. The 72 entry assumes the whole sale happens into the gap zone, which this plan no longer relies on, so the average sale price is more like 69-70. And the 65 stop should be treated as a closing-basis trigger near 65.8, not a resting order, since a gap would skip it either way. That keeps the Sell, keeps the first cut independent of a fill, and leaves enough exposure that a good print isn't something we only watch.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: You've both moved a long way, so I'll point at what's left rather than re-argue the early rounds. The trader's plan said to carry 50-60% through the print. You're now at about half and a third to 40%. The disagreement is about 10-15 points of position, and I don't think the data can settle that.

Conservative, I'll start with your sizing math, because it's the best argument you've made and it still has a hole. You stacked a 10% gap onto 7% of follow-through and got a 2.8-point difference between half and a third. But you said yourself that after the print the hold should rest on the quarter's numbers, meaning cash conversion, the content spend ratio and the buyback pace. April's follow-through wasn't a second gap. It was a grind from 97 to 71 over two months, with plenty of sessions to act on evidence. The drift tail is exactly what your post-print review is for, so you can't charge it to the carry size. Size protects against the gap, and the review protects against the drift. Once you separate them, the difference is back near 1.7 points, which is Aggressive's number. You also cap the bounce at 10% because of the 74.86 and 75.60 resistance. But that's a choice of scenario. The July rebound ran 22% to 82.73, and a good print against an easy margin comparison doesn't have to respect resistance from a stock that gaps. On that path the extra 17 points earn about 3.7, and the stacked-bad and stacked-good cases roughly cancel.

I'd also push back on "a trend with ADX at 35 will cost us over the next eight to ten sessions." ADX tells you the trend is real, not that it continues. It went from 9 to 35 in two weeks mostly because of one gap and its follow-through, and it's rising while the daily TD-9, RSI 32 and z-scores near -1.6 all say the move is mature. Continuation is the higher-probability call, as the technical report says, but "will cost us" is more certainty than the evidence gives. Your first cut to two-thirds of standard exposure is fine. Going from there to a third before the print makes you roughly 15-17% long after a 65.8 trigger, which is the lock-in problem Neutral and Aggressive already named.

Aggressive, you've been more honest than before, but two things remain. First, a fifth over two sessions is thin. You've accepted that event risk doesn't wait for earnings, and that the 9/18 gap on 114M shares had no identified cause. Selling only 20% and then waiting on a ladder that may not fill leaves you near full size through the part of the calendar you admit you know least about. A quarter, staggered, costs you almost nothing in upside and is more consistent with your own concession. Second, "17 points is under two points either way" is correct, but it proves too much. By that logic the whole Sell is worth a few points, so the plan's value lies in robustness, not in squeezing the carry. And Conservative's question, where does the half you keep go if we rally into 74.86 and 75.60, still has no answer in your plan. Your reply to the July episode can't just be "we'd have trimmed."

So here's where I land, and it does move toward Conservative on one point. Check the earnings date today, because it sets the clock. Sell about a quarter over tomorrow and Monday into any intraday strength toward 69-70. Take the second tranche toward roughly 50% with limits at 71-72.5, backstopped at market about five sessions before the print, or immediately if the date is inside a week. Then add one rule neither of you wrote. The retained sleeve is there to participate in the print, but if the stock rallies into 74-76 and stalls before the date, a bounce has already paid us and I'd shave it to about 40-45%. A close above 74.86 would change that, because the daily trend would have flipped and I'd stop trimming. So I'd carry 40-45% through the print, nearer 40% if the date is inside a week. A 10% gap costs about 4-4.5 points at that size, which I can live with. A clean print still gets real participation, and the carry sits below the trader's 50-60% for exactly the reason Conservative gives, which is that after a gap the stop doesn't help.

A heavy-volume close below roughly 65.8 cuts a third to half of what's left before the print. After the print, no reflex either way. Rebuy about half of what was sold if the stock holds its reaction through the next session, and judge the rest on FCF against Q3'25's 2.66B, the content cash-to-amortization ratio and the buyback pace. That 2.66B comparison is less steep than the 74% jump suggests, since Q2 carried a $1.3B working-capital drain. But I wouldn't assume that reverses.

The Sell stays. I'd just run it as a staged, evidence-driven reduction to about 40-45%, not a bet on either tail.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: Conservative, your best point this round is about the carry numbers, and it hits my plan as much as Aggressive's. The 40-45% figure only appears if the stock rallies into 74-76 and stalls. In the path that hurts, where it grinds lower, the limits at 71-72.5 never fill and the backstop takes us to 50%. That is the bottom of the trader's original range, so the lower carry only shows up where we didn't need it. I'm fixing that. The backstop target becomes about 45%, reached at market if the limits haven't filled, with 40% if the date is inside a week. The stall-at-resistance shave becomes a bonus, not the thing the plan leans on.

I don't accept the next step, though. You say the sleeve only has an exit in paths that didn't hurt, because a gap skips 65.8. That's true for a gap, but a grind through 67.60 and 66.27 down to a heavy-volume close under 65.8 is exactly where the rule works. April's follow-through was a grind, and so was the slide into the July low. Only the gap itself is unprotected, and that's what size is for. Your 2.8-point difference between half and a third also used a 50% carry. Against 45%, a 10% gap plus 7% drift costs about 7.7 points versus 5.6 at a third, a gap of 2.1. The upside is similar. A 22% run like July's is worth about 9.9 versus 7.3, a gap of 2.6, and a 10% bounce is worth 1.2 either way. The stacked-bad case and the full-run case roughly cancel again. You also used the 74.86 rebuy to argue the cut side doesn't miss the rally, but your latest plan only rebuys after the print. So you do miss a pre-print bounce, though it's small.

Aggressive, you moved a lot, and I'll credit that. But you're arguing against a stale version of the other side. Conservative's new rule cuts a third of what's left on the 65.8 close, so he lands around 22-25%, not 15-17%. The "watching from 15% and calling it prudence" line no longer describes anything on the table. Your drift argument is also weaker than it sounds. Saying 97 was high 30s on normalized EPS and 61 is about 24x helps, but that EPS rests on our own estimate of a $2.8B item nobody could identify. The stock already de-rated from 29-30x to 26-27x and kept falling, so a lower multiple isn't a floor. And your FCF arithmetic is fair. Adding back the $1.3B drain gets Q2 to about $2.8B, above Q3'25's $2.66B. But that assumes the drain doesn't recur, and the 1.15x content ratio is already inside that number.

Here is where I land. We're now arguing over roughly a dozen points of position, which is about a point of P&L on a 10% move either way. With no earnings date, no sentiment and no news, that's below what this data can resolve. So I'd choose on whether each rule can actually be executed, not on who's likelier to be right about direction.

First, check the earnings date, and check where the stock is trading now, since our data stops at the October 1 close. Second, sell about a quarter over the next two sessions, doing roughly half of it without waiting for a bounce and the rest into any strength toward 69-70. Third, put limits at 71-72.5 for the next tranche, with the market backstop at 45% about five sessions before the print, or immediately if the date is inside a week. Fourth, carry about 45% through the print, 40% if the date is close. A 10% gap costs about 4.5 points, which is survivable. Fifth, cut a third of what's left on a heavy-volume close below roughly 65.8, and stop trimming above a daily close over 74.86. Sixth, after the print, don't act reflexively either way. Rebuy about half of what was sold if the stock holds its reaction through the next full session. Judge the rest on FCF against Q3'25, the content cash-to-amortization ratio and the buyback pace, not on a multiple that depends on my own estimate.

This keeps real participation if the print is good. It also makes the downside carry the same in every path, and that was the flaw Conservative found.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: Aggressive, one correction first. Your "a third requires selling two-thirds into a TD-9" line argues against a plan that is no longer on the table. Conservative is now at a flat 40% carry, so the first sale is a quarter, the same as yours and mine. What's left between you is about five points of position, which on a 10% move is half a point of P&L. Your rebuy-premium point is fair, but it applies to any sale, including your own quarter, and at five points of difference it's tiny. I'd also resist the idea that empty tools make the next two weeks symmetric. We don't know the print's direction, but the tape has had a one-way drift and all three heavy-volume gaps were down. That doesn't say the print will be bad. It says the downside tail has actually occurred here, while a clean 8-10% gap up hasn't, so I'm comfortable leaning slightly lower than the 45% you want.

Conservative, you earned two things this round. Dropping the volume filter was right. Recent down days ran 36 and 42 million shares, so "heavy" would have meant a gap-sized day and the rule would only fire when it can't help. A plain close below about 65.8 is already under the lower band, and since it only cuts a third of what's left, a whipsaw costs little. Your default for an unconfirmed date is right too. A plan that waits on information it may not get isn't a plan. In practice the date is a two-minute lookup, but if it can't be pinned down by Monday's close, assume mid-October and run the calendar.

Where I still push back is on 35% inside a week and on treating the post-gap review as worthless. You say the review is a judgment call made while the stock is down ten percent. True, but the alternative is a mechanical rule that dumps the remainder at the lows, and the one thing we know about post-gap prices here is that after July's gap the stock ran 22%. Size protects against the gap, and judgment on cash conversion and buyback pace handles what follows. I'd keep them separate rather than shrinking the carry to cover both. Your point about unknown holdings is the best new one, though. Everything here is a fraction of a standard position. If you're flat, don't start a position before the print. If you're already below 45% of what you'd normally hold, don't sell more, and let the 65.8 rule do the work. If you're oversized, get to standard first and then apply the plan.

So here's where I land. The carry is 40 to 45%, and I'm moving to the low end. With the date likely within two weeks and the starting size unknown, 40% is the practical number. I'd go to 35% only if the print is inside a week and the stock has already slipped through 67.60. I'm not going lower, because that's the 15-25% underweight that needs a rebuy rule we can't pin down.

The sequence is this. Check the live price and the earnings date first, since our data stops at yesterday's close. Sell about a quarter over the next two sessions, half of it without waiting for a bounce and half into strength toward 69 to 70, so the average sale is nearer 69 or 70 than the trader's 72. Put limits at 71 to 72.5 for the next tranche, with a market backstop to 40% about five sessions before the print. That's around October 8 if the print is mid-month, and immediately if the date is inside a week. Cut a third of what's left on any close below 65.8, and stop trimming on a daily close above 74.86. If the bounce stalls in the 74 to 76 area before the print, shave a bit more as a bonus, but don't count on it. After the print, rebuy about half of what was sold if the stock holds its reaction through the next full session. Judge the rest on free cash flow against Q3'25's $2.66B, the content cash-to-amortization ratio, and the buyback pace.

That plan gets us out of the way of the gap risk we've seen three times, doesn't depend on any fill, and leaves enough exposure that a good print isn't just something to watch.

FINAL TRANSACTION PROPOSAL: SELL

V. Portfolio Manager Decision

Portfolio Manager

Rating: Underweight

Executive Summary: Cut NFLX to about 40-45% of a standard position before the Q3 print, or 40% if the print is less than a week away. Do not exit, and add no new money before the print. Sell about a quarter of the position over the next two sessions: half without waiting for a bounce and half into strength near $69-70. Place limits at $71-72.5 for the next tranche. If those limits haven't filled about five sessions before earnings, sell at market to reach the target size; if the date can't be confirmed by Monday Oct 5, assume mid-October and act around Oct 8. Before the print, cut a third of what's left on any close below about $65.8 and stop trimming on a daily close above $74.86. Re-add only on the Q3 cash-conversion evidence.

Investment Thesis: The analysts agree on direction and differ only on size. The Research Manager, the trader and all three risk analysts end at "reduce, don't exit." That is an Underweight call. The trader's "Sell" label really describes a trim.

Why reduce: (1) The trend is down on every timeframe. Weekly, monthly and daily SuperTrend all point down (86.41 / 106.13 / 74.86). ADX rose from 9 to 34.9 in two weeks. Price is below the 10 EMA, 50 SMA and 200 SMA (71.09 / 75.60 / 84.20). MACD is -2.31 against a signal of -1.57, and OBV is at its window low with no divergence. (2) Valuation is fair, not cheap. The stock trades at about 26-30x normalized or SBC-adjusted cash earnings, which gives an FCF yield of about 3-3.4%. (3) Cash conversion is weakening. Q2 FCF fell 33% year over year to $1.53B. Content cash spend ran about 1.15x amortization, up from 1.03x. Opex grew 17.7% against revenue growth of 13.4%. The H1 buybacks were only funded because of the unexplained $2.85B Q1 item. (4) Event risk can't be seen in advance. All three heavy-volume gaps were downward (4/17, 7/17, 9/18), the cause of the 9/18 gap is unknown, and the earnings date isn't confirmed.

Why not Sell: the business is sound. Revenue grew 13.4%, operating margin is 33.4%, interest coverage is about 24x and the share count fell about 2%. The stock is already 37% below its April high. Short-term exhaustion signals are present: a completed daily TD-9, RSI at 32.45 and z-scores near -1.6. The July gap at a similar level led to a 22% rally. On the debate's own figures, a carry of about 40-45% versus a third differs by only 1-2 points of P&L in either tail.

Sizing comes from the Conservative analyst's path-dependence point. The trader's 50-60% carry only drops lower if the stock bounces, so in the bad path the plan carried the most. A calendar backstop to a fixed 40-45% fixes that. I also adopted his change to drop the volume filter on the $65.8 trigger, because recent down days ran only 36-42M shares. I rejected his one-third carry because it leaves a rebuy problem and a structural underweight in a sound business.

What would change the view. Upgrade to Hold or Overweight on an Intact Q3: FCF of at least $2.66B, FCF before working capital of at least $2.5B, net debt of $7.0B or less, operating margin of at least 31%, opex growth of 18% or less, and a price under about 30x cash earnings (~$72). A close above $74.86 that flips the daily SuperTrend would also count. Downgrade to Sell on a Broken Q3: FCF below $2.0B, operating margin below 30%, opex growth above 20%, or a content ratio of at least 1.15x for a second straight quarter.

Price target of $65 is a probability-weighted value of the three Q3 outcomes: Intact at 25% x $72 (the 30x cash-earnings ceiling), Amber at 45% x $65.5 (the July low and lower Bollinger band zone of 65.08-66.27), and Broken at 30% x $58 (18x Q2 run-rate EPS of $3.20). This works out to about $64.9.

Current Price: 67.85

Price Target: 65.0

Confidence: Medium

Time Horizon: 1-3 months